TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
hsa04010	MAPK signaling pathway	0.000495366461088389	-7.61021274387019	255	20	0.0836820083682008	239	6908	5599,627,2247,9175,3164,5922,4914,1852,22808,785,7048,9252,9965,2122,6196,4616,5062,776,1649,4208	MAPK8,BDNF,FGF2,MAP3K13,NR4A1,RASA2,NTRK1,DUSP9,MRAS,CACNB4,TGFBR2,RPS6KA5,FGF19,MECOM,RPS6KA2,GADD45B,PAK2,CACNA1D,DDIT3,MEF2C
ko04010	MAPK signaling pathway	0.000495366461088389	-7.61021274387019	255	20	0.0836820083682008	239	6908	5599,627,2247,9175,3164,5922,4914,1852,22808,9252,785,7048,9965,2122,6196,5062,4616,776,1649,4208	MAPK8,BDNF,FGF2,MAP3K13,NR4A1,RASA2,NTRK1,DUSP9,MRAS,RPS6KA5,CACNB4,TGFBR2,FGF19,MECOM,RPS6KA2,PAK2,GADD45B,CACNA1D,DDIT3,MEF2C
hsa04151	PI3K-Akt signaling pathway	0.00083011053416981	-7.09395169234189	346	24	0.100418410041841	239	6908	2247,3164,2792,10319,1287,9586,5585,7422,5291,9965,5523,1293,54541,3914,6696,3480,3673,4233,5106,5522,1288,1021,285,4602	FGF2,NR4A1,GNGT1,LAMC3,COL4A5,CREB5,PKN1,VEGFA,PIK3CB,FGF19,PPP2R3A,COL6A3,DDIT4,LAMB3,SPP1,IGF1R,ITGA2,MET,PCK2,PPP2R2C,COL4A6,CDK6,ANGPT2,MYB
ko04151	PI3K-Akt signaling pathway	0.00083011053416981	-7.09395169234189	346	24	0.100418410041841	239	6908	2247,3164,2792,10319,1287,9586,5585,7422,5291,9965,5523,1293,54541,3914,6696,3480,3673,4233,5106,5522,1288,1021,285,4602	FGF2,NR4A1,GNGT1,LAMC3,COL4A5,CREB5,PKN1,VEGFA,PIK3CB,FGF19,PPP2R3A,COL6A3,DDIT4,LAMB3,SPP1,IGF1R,ITGA2,MET,PCK2,PPP2R2C,COL4A6,CDK6,ANGPT2,MYB
hsa03060	Protein export	0.00095930586453605	-6.94930059280969	23	5	0.0209205020920502	239	6908	58477,83943,196294,29927,7095	SRPRB,IMMP2L,IMMP1L,SEC61A1,SEC62
ko03060	Protein export	0.00095930586453605	-6.94930059280969	23	5	0.0209205020920502	239	6908	58477,83943,29927,196294,7095	SRPRB,IMMP2L,SEC61A1,IMMP1L,SEC62
ko04728	Dopaminergic synapse	0.0016171944922503	-6.4270624259354	129	12	0.0502092050209205	239	6908	5599,406,2792,3800,9586,776,5522,9575,23236,5330,4129,5523	MAPK8,ARNTL,GNGT1,KIF5C,CREB5,CACNA1D,PPP2R2C,CLOCK,PLCB1,PLCB2,MAOB,PPP2R3A
hsa04728	Dopaminergic synapse	0.0016171944922503	-6.4270624259354	129	12	0.0502092050209205	239	6908	5599,406,2792,3800,9586,776,5522,9575,23236,5330,4129,5523	MAPK8,ARNTL,GNGT1,KIF5C,CREB5,CACNA1D,PPP2R2C,CLOCK,PLCB1,PLCB2,MAOB,PPP2R3A
hsa04510	Focal adhesion	0.00209664366387031	-6.16741746812512	207	16	0.0669456066945607	239	6908	5599,10319,1287,857,7422,5291,1293,3914,6696,2534,3480,5062,3673,4233,1288,858	MAPK8,LAMC3,COL4A5,CAV1,VEGFA,PIK3CB,COL6A3,LAMB3,SPP1,FYN,IGF1R,PAK2,ITGA2,MET,COL4A6,CAV2
ko04510	Focal adhesion	0.00209664366387031	-6.16741746812512	207	16	0.0669456066945607	239	6908	5599,10319,1287,857,7422,5291,1293,3914,6696,2534,3480,5062,3673,4233,1288,858	MAPK8,LAMC3,COL4A5,CAV1,VEGFA,PIK3CB,COL6A3,LAMB3,SPP1,FYN,IGF1R,PAK2,ITGA2,MET,COL4A6,CAV2
hsa04014	Ras signaling pathway	0.00215211820208365	-6.14130271157221	227	17	0.0711297071129707	239	6908	5599,2247,5922,2792,283455,22808,7422,2113,5291,9965,3363,3480,5062,5337,4233,9771,285	MAPK8,FGF2,RASA2,GNGT1,KSR2,MRAS,VEGFA,ETS1,PIK3CB,FGF19,HTR7,IGF1R,PAK2,PLD1,MET,RAPGEF5,ANGPT2
hsa00280	Valine, leucine and isoleucine degradation	0.00526772163683598	-5.24615733688521	47	6	0.0251046025104603	239	6908	5096,217,1962,594,5095,56922	PCCB,ALDH2,EHHADH,BCKDHB,PCCA,MCCC1
ko00280	Valine, leucine and isoleucine degradation	0.00526772163683598	-5.24615733688521	47	6	0.0251046025104603	239	6908	5096,217,1962,594,5095,56922	PCCB,ALDH2,EHHADH,BCKDHB,PCCA,MCCC1
hsa04015	Rap1 signaling pathway	0.00626813917433986	-5.07227575078786	211	15	0.0627615062761506	239	6908	64411,3480,2247,5584,22808,4233,7422,8631,23236,5330,5217,5291,9771,9965,285	ARAP3,IGF1R,FGF2,PRKCI,MRAS,MET,VEGFA,SKAP1,PLCB1,PLCB2,PFN2,PIK3CB,RAPGEF5,FGF19,ANGPT2
ko04015	Rap1 signaling pathway	0.00626813917433986	-5.07227575078786	211	15	0.0627615062761506	239	6908	64411,3480,2247,5584,22808,4233,7422,8631,23236,5330,5217,5291,9771,9965,285	ARAP3,IGF1R,FGF2,PRKCI,MRAS,MET,VEGFA,SKAP1,PLCB1,PLCB2,PFN2,PIK3CB,RAPGEF5,FGF19,ANGPT2
ko04144	Endocytosis	0.0078730798316775	-4.84430595490012	258	17	0.0711297071129707	239	6908	64411,7879,4914,3800,857,7048,7037,23527,3480,50807,9922,5584,138429,5337,4233,27128,858	ARAP3,RAB7A,NTRK1,KIF5C,CAV1,TGFBR2,TFRC,ACAP2,IGF1R,ASAP1,IQSEC1,PRKCI,PIP5KL1,PLD1,MET,CYTH4,CAV2
hsa04144	Endocytosis	0.0078730798316775	-4.84430595490012	258	17	0.0711297071129707	239	6908	64411,7879,4914,3800,857,7048,7037,23527,3480,50807,9922,5584,138429,5337,4233,27128,858	ARAP3,RAB7A,NTRK1,KIF5C,CAV1,TGFBR2,TFRC,ACAP2,IGF1R,ASAP1,IQSEC1,PRKCI,PIP5KL1,PLD1,MET,CYTH4,CAV2
hsa05222	Small cell lung cancer	0.009476147505241	-4.65897742661416	86	8	0.0334728033472803	239	6908	3673,10319,1287,2272,1288,1021,5291,3914	ITGA2,LAMC3,COL4A5,FHIT,COL4A6,CDK6,PIK3CB,LAMB3
ko05222	Small cell lung cancer	0.009476147505241	-4.65897742661416	86	8	0.0334728033472803	239	6908	3673,10319,1287,2272,1288,1021,5291,3914	ITGA2,LAMC3,COL4A5,FHIT,COL4A6,CDK6,PIK3CB,LAMB3
hsa04512	ECM-receptor interaction	0.0101336348704281	-4.59189520273066	87	8	0.0334728033472803	239	6908	6696,3339,3673,10319,1287,1288,1293,3914	SPP1,HSPG2,ITGA2,LAMC3,COL4A5,COL4A6,COL6A3,LAMB3
ko04512	ECM-receptor interaction	0.0101336348704281	-4.59189520273066	87	8	0.0334728033472803	239	6908	6696,3339,3673,10319,1287,1288,1293,3914	SPP1,HSPG2,ITGA2,LAMC3,COL4A5,COL4A6,COL6A3,LAMB3
hsa05146	Amoebiasis	0.0115037646980849	-4.46508093213432	107	9	0.0376569037656904	239	6908	384,7879,10319,1287,1288,5330,23236,5291,3914	ARG2,RAB7A,LAMC3,COL4A5,COL4A6,PLCB2,PLCB1,PIK3CB,LAMB3
ko05146	Amoebiasis	0.0115037646980849	-4.46508093213432	107	9	0.0376569037656904	239	6908	384,7879,10319,1287,1288,5330,23236,5291,3914	ARG2,RAB7A,LAMC3,COL4A5,COL4A6,PLCB2,PLCB1,PIK3CB,LAMB3
hsa05200	Pathways in cancer	0.0187991927720204	-3.97394134772657	397	22	0.0920502092050209	239	6908	5599,2736,2247,4914,2792,10319,1287,7422,7048,23236,2113,5291,9965,3914,2122,3480,3673,5337,4233,5330,1288,1021	MAPK8,GLI2,FGF2,NTRK1,GNGT1,LAMC3,COL4A5,VEGFA,TGFBR2,PLCB1,ETS1,PIK3CB,FGF19,LAMB3,MECOM,IGF1R,ITGA2,PLD1,MET,PLCB2,COL4A6,CDK6
ko04973	Carbohydrate digestion and absorption	0.0188112842050071	-3.97329836553782	45	5	0.0209205020920502	239	6908	483,776,5330,5291,3099	ATP1B3,CACNA1D,PLCB2,PIK3CB,HK2
hsa04973	Carbohydrate digestion and absorption	0.0188112842050071	-3.97329836553782	45	5	0.0209205020920502	239	6908	483,776,5330,5291,3099	ATP1B3,CACNA1D,PLCB2,PIK3CB,HK2
ko04722	Neurotrophin signaling pathway	0.0228480955232673	-3.77888751201843	120	9	0.0376569037656904	239	6908	5599,10019,627,6196,4914,9500,4916,9252,5291	MAPK8,SH2B3,BDNF,RPS6KA2,NTRK1,MAGED1,NTRK3,RPS6KA5,PIK3CB
ko04071	Sphingolipid signaling pathway	0.0228480955232673	-3.77888751201843	120	9	0.0376569037656904	239	6908	5599,2534,259230,5337,5522,5330,23236,5291,5523	MAPK8,FYN,SGMS1,PLD1,PPP2R2C,PLCB2,PLCB1,PIK3CB,PPP2R3A
hsa04722	Neurotrophin signaling pathway	0.0228480955232673	-3.77888751201843	120	9	0.0376569037656904	239	6908	5599,10019,627,6196,4914,9500,4916,9252,5291	MAPK8,SH2B3,BDNF,RPS6KA2,NTRK1,MAGED1,NTRK3,RPS6KA5,PIK3CB
hsa04071	Sphingolipid signaling pathway	0.0228480955232673	-3.77888751201843	120	9	0.0376569037656904	239	6908	5599,2534,259230,5337,5522,5330,23236,5291,5523	MAPK8,FYN,SGMS1,PLD1,PPP2R2C,PLCB2,PLCB1,PIK3CB,PPP2R3A
ko04930	Type II diabetes mellitus	0.024263472120297	-3.71878326450771	48	5	0.0209205020920502	239	6908	8660,5599,776,5291,3099	IRS2,MAPK8,CACNA1D,PIK3CB,HK2
hsa04930	Type II diabetes mellitus	0.024263472120297	-3.71878326450771	48	5	0.0209205020920502	239	6908	8660,5599,776,5291,3099	IRS2,MAPK8,CACNA1D,PIK3CB,HK2
ko05212	Pancreatic cancer	0.0259504358839325	-3.65156687244262	66	6	0.0251046025104603	239	6908	5599,5337,7422,7048,5291,1021	MAPK8,PLD1,VEGFA,TGFBR2,PIK3CB,CDK6
hsa05212	Pancreatic cancer	0.0259504358839325	-3.65156687244262	66	6	0.0251046025104603	239	6908	5599,5337,7422,7048,5291,1021	MAPK8,PLD1,VEGFA,TGFBR2,PIK3CB,CDK6
ko00330	Arginine and proline metabolism	0.0262845186478984	-3.63877515768425	49	5	0.0209205020920502	239	6908	384,4842,112849,217,4129	ARG2,NOS1,L3HYPDH,ALDH2,MAOB
hsa00330	Arginine and proline metabolism	0.0262845186478984	-3.63877515768425	49	5	0.0209205020920502	239	6908	384,112849,4842,217,4129	ARG2,L3HYPDH,NOS1,ALDH2,MAOB
ko05230	Central carbon metabolism in cancer	0.0277088487981599	-3.58600346560541	67	6	0.0251046025104603	239	6908	4916,4233,5291,4914,8140,3099	NTRK3,MET,PIK3CB,NTRK1,SLC7A5,HK2
hsa05230	Central carbon metabolism in cancer	0.0277088487981599	-3.58600346560541	67	6	0.0251046025104603	239	6908	4916,4233,5291,4914,8140,3099	NTRK3,MET,PIK3CB,NTRK1,SLC7A5,HK2
hsa04115	p53 signaling pathway	0.0295443489370267	-3.52186279074388	68	6	0.0251046025104603	239	6908	545,83667,5366,1021,4616,4194	ATR,SESN2,PMAIP1,CDK6,GADD45B,MDM4
ko04115	p53 signaling pathway	0.0295443489370267	-3.52186279074388	68	6	0.0251046025104603	239	6908	545,83667,5366,1021,4616,4194	ATR,SESN2,PMAIP1,CDK6,GADD45B,MDM4
ko00220	Arginine biosynthesis	0.0301766724798454	-3.50068608752472	20	3	0.0125523012552301	239	6908	84706,384,4842	GPT2,ARG2,NOS1
hsa00220	Arginine biosynthesis	0.0301766724798454	-3.50068608752472	20	3	0.0125523012552301	239	6908	84706,384,4842	GPT2,ARG2,NOS1
hsa04360	Axon guidance	0.0315168511347641	-3.45723291952967	127	9	0.0376569037656904	239	6908	2534,5062,57522,5361,4233,8829,90249,2047,9901	FYN,PAK2,SRGAP1,PLXNA1,MET,NRP1,UNC5A,EPHB1,SRGAP3
ko04360	Axon guidance	0.0315168511347641	-3.45723291952967	127	9	0.0376569037656904	239	6908	2534,5062,57522,5361,4233,8829,90249,2047,9901	FYN,PAK2,SRGAP1,PLXNA1,MET,NRP1,UNC5A,EPHB1,SRGAP3
hsa00250	Alanine, aspartate and glutamate metabolism	0.0315683418479784	-3.45560050082049	35	4	0.0167364016736402	239	6908	84706,339983,440,2571	GPT2,NAT8L,ASNS,GAD1
ko00250	Alanine, aspartate and glutamate metabolism	0.0315683418479784	-3.45560050082049	35	4	0.0167364016736402	239	6908	84706,339983,440,2571	GPT2,NAT8L,ASNS,GAD1
ko04261	Adrenergic signaling in cardiomyocytes	0.0321298288402166	-3.43797043297044	148	10	0.0418410041841004	239	6908	776,9586,483,5522,785,23236,9252,5330,5291,5523	CACNA1D,CREB5,ATP1B3,PPP2R2C,CACNB4,PLCB1,RPS6KA5,PLCB2,PIK3CB,PPP2R3A
hsa04261	Adrenergic signaling in cardiomyocytes	0.0321298288402166	-3.43797043297044	148	10	0.0418410041841004	239	6908	776,9586,483,5522,785,23236,9252,5330,5291,5523	CACNA1D,CREB5,ATP1B3,PPP2R2C,CACNB4,PLCB1,RPS6KA5,PLCB2,PIK3CB,PPP2R3A
hsa04974	Protein digestion and absorption	0.0338970006887538	-3.3844287437679	89	7	0.0292887029288703	239	6908	1803,1287,483,1288,117247,1293,1303	DPP4,COL4A5,ATP1B3,COL4A6,SLC16A10,COL6A3,COL12A1
ko04974	Protein digestion and absorption	0.0338970006887538	-3.3844287437679	89	7	0.0292887029288703	239	6908	1803,1287,483,1288,117247,1293,1303	DPP4,COL4A5,ATP1B3,COL4A6,SLC16A10,COL6A3,COL12A1
hsa05218	Melanoma	0.0355240113540819	-3.33754643496872	71	6	0.0251046025104603	239	6908	4233,3480,2247,5291,9965,1021	MET,IGF1R,FGF2,PIK3CB,FGF19,CDK6
hsa00562	Inositol phosphate metabolism	0.0355240113540819	-3.33754643496872	71	6	0.0251046025104603	239	6908	23007,138429,5330,23236,5291,5305	PLCH1,PIP5KL1,PLCB2,PLCB1,PIK3CB,PIP4K2A
ko00562	Inositol phosphate metabolism	0.0355240113540819	-3.33754643496872	71	6	0.0251046025104603	239	6908	138429,23007,23236,5330,5291,5305	PIP5KL1,PLCH1,PLCB1,PLCB2,PIK3CB,PIP4K2A
ko05218	Melanoma	0.0355240113540819	-3.33754643496872	71	6	0.0251046025104603	239	6908	4233,3480,2247,5291,9965,1021	MET,IGF1R,FGF2,PIK3CB,FGF19,CDK6
hsa04931	Insulin resistance	0.0380006651932305	-3.27015161432395	111	8	0.0334728033472803	239	6908	8660,5599,57761,6196,9586,5106,5291,22877	IRS2,MAPK8,TRIB3,RPS6KA2,CREB5,PCK2,PIK3CB,MLXIP
hsa04726	Serotonergic synapse	0.0397542694709263	-3.22503803557601	112	8	0.0334728033472803	239	6908	3363,2792,7220,5742,776,4129,5330,23236	HTR7,GNGT1,TRPC1,PTGS1,CACNA1D,MAOB,PLCB2,PLCB1
hsa04068	FoxO signaling pathway	0.0422507383619858	-3.16413344930833	134	9	0.0376569037656904	239	6908	8660,5599,10365,3480,4616,9140,5106,7048,5291	IRS2,MAPK8,KLF2,IGF1R,GADD45B,ATG12,PCK2,TGFBR2,PIK3CB
hsa04923	Regulation of lipolysis in adipocytes	0.0434297681609132	-3.13661017067408	56	5	0.0209205020920502	239	6908	8660,5742,5140,11343,5291	IRS2,PTGS1,PDE3B,MGLL,PIK3CB
hsa05202	Transcriptional misregulation in cancer	0.0457450773294833	-3.08467109240539	179	11	0.0460251046025105	239	6908	8464,7403,3480,4291,2119,4914,5090,4233,7048,1649,4208	SUPT3H,KDM6A,IGF1R,MLF1,ETV5,NTRK1,PBX3,MET,TGFBR2,DDIT3,MEF2C
ko05202	Transcriptional misregulation in cancer	0.0457450773294833	-3.08467109240539	179	11	0.0460251046025105	239	6908	8464,7403,3480,4291,2119,4914,5090,4233,7048,1649,4208	SUPT3H,KDM6A,IGF1R,MLF1,ETV5,NTRK1,PBX3,MET,TGFBR2,DDIT3,MEF2C
ko00561	Glycerolipid metabolism	0.0524343913850148	-2.94819257880013	59	5	0.0209205020920502	239	6908	217,11343,1608,56895,23175	ALDH2,MGLL,DGKG,AGPAT4,LPIN1
hsa00561	Glycerolipid metabolism	0.0524343913850148	-2.94819257880013	59	5	0.0209205020920502	239	6908	217,11343,1608,56895,23175	ALDH2,MGLL,DGKG,AGPAT4,LPIN1
hsa04310	Wnt signaling pathway	0.0552169970686005	-2.89648445518665	141	9	0.0376569037656904	239	6908	5599,4316,8607,79718,166336,6907,23236,5330,22943	MAPK8,MMP7,RUVBL1,TBL1XR1,PRICKLE2,TBL1X,PLCB1,PLCB2,DKK1
ko04310	Wnt signaling pathway	0.0552169970686005	-2.89648445518665	141	9	0.0376569037656904	239	6908	5599,4316,8607,79718,166336,6907,23236,5330,22943	MAPK8,MMP7,RUVBL1,TBL1XR1,PRICKLE2,TBL1X,PLCB1,PLCB2,DKK1
hsa04925	Aldosterone synthesis and secretion	0.0608197995388986	-2.79983989271174	81	6	0.0251046025104603	239	6908	9586,776,57118,23236,5330,3164	CREB5,CACNA1D,CAMK1D,PLCB1,PLCB2,NR4A1
ko04925	Aldosterone synthesis and secretion	0.0608197995388986	-2.79983989271174	81	6	0.0251046025104603	239	6908	9586,776,57118,23236,5330,3164	CREB5,CACNA1D,CAMK1D,PLCB1,PLCB2,NR4A1
hsa04152	AMPK signaling pathway	0.0626617958283057	-2.77000333398519	123	8	0.0334728033472803	239	6908	8660,3480,84254,9586,5522,5106,5291,5523	IRS2,IGF1R,CAMKK1,CREB5,PPP2R2C,PCK2,PIK3CB,PPP2R3A
ko04152	AMPK signaling pathway	0.0626617958283057	-2.77000333398519	123	8	0.0334728033472803	239	6908	8660,3480,84254,9586,5522,5106,5291,5523	IRS2,IGF1R,CAMKK1,CREB5,PPP2R2C,PCK2,PIK3CB,PPP2R3A
hsa04022	cGMP-PKG signaling pathway	0.0636409788877568	-2.75449769398791	167	10	0.0418410041841004	239	6908	8660,10335,776,9586,483,23236,5140,5330,5291,4208	IRS2,MRVI1,CACNA1D,CREB5,ATP1B3,PLCB1,PDE3B,PLCB2,PIK3CB,MEF2C
ko04022	cGMP-PKG signaling pathway	0.0636409788877568	-2.75449769398791	167	10	0.0418410041841004	239	6908	8660,10335,776,9586,483,23236,5140,5330,5291,4208	IRS2,MRVI1,CACNA1D,CREB5,ATP1B3,PLCB1,PDE3B,PLCB2,PIK3CB,MEF2C
hsa00650	Butanoate metabolism	0.0649740264299636	-2.73376768233039	27	3	0.0125523012552301	239	6908	1962,2571,622	EHHADH,GAD1,BDH1
ko00650	Butanoate metabolism	0.0649740264299636	-2.73376768233039	27	3	0.0125523012552301	239	6908	1962,2571,622	EHHADH,GAD1,BDH1
ko00640	Propanoate metabolism	0.0709846356646733	-2.64529182444759	28	3	0.0125523012552301	239	6908	5096,1962,5095	PCCB,EHHADH,PCCA
hsa00640	Propanoate metabolism	0.0709846356646733	-2.64529182444759	28	3	0.0125523012552301	239	6908	5096,1962,5095	PCCB,EHHADH,PCCA
ko05211	Renal cell carcinoma	0.0773652271584026	-2.55921786085399	66	5	0.0209205020920502	239	6908	4233,7422,2113,5291,5062	MET,VEGFA,ETS1,PIK3CB,PAK2
hsa05211	Renal cell carcinoma	0.0773652271584026	-2.55921786085399	66	5	0.0209205020920502	239	6908	4233,7422,2113,5291,5062	MET,VEGFA,ETS1,PIK3CB,PAK2
hsa04914	Progesterone-mediated oocyte maturation	0.0800791377346652	-2.52473991158228	87	6	0.0251046025104603	239	6908	5599,22849,6196,3480,5140,5291	MAPK8,CPEB3,RPS6KA2,IGF1R,PDE3B,PIK3CB
ko04914	Progesterone-mediated oocyte maturation	0.0800791377346652	-2.52473991158228	87	6	0.0251046025104603	239	6908	5599,22849,6196,3480,5140,5291	MAPK8,CPEB3,RPS6KA2,IGF1R,PDE3B,PIK3CB
ko00510	N-Glycan biosynthesis	0.0883253913745141	-2.42672765467384	49	4	0.0167364016736402	239	6908	10195,6184,6480,4249	ALG3,RPN1,ST6GAL1,MGAT5
hsa00510	N-Glycan biosynthesis	0.0883253913745141	-2.42672765467384	49	4	0.0167364016736402	239	6908	10195,6184,6480,4249	ALG3,RPN1,ST6GAL1,MGAT5
hsa04725	Cholinergic synapse	0.0893767353435017	-2.41489486172567	111	7	0.0292887029288703	239	6908	2534,9586,776,23236,5330,5291,2792	FYN,CREB5,CACNA1D,PLCB1,PLCB2,PIK3CB,GNGT1
ko00512	Mucin type O-Glycan biosynthesis	0.0904275585745306	-2.40320620655361	31	3	0.0125523012552301	239	6908	2591,79623,374378	GALNT3,GALNT14,GALNT18
hsa00512	Mucin type O-Glycan biosynthesis	0.0904275585745306	-2.40320620655361	31	3	0.0125523012552301	239	6908	2591,79623,374378	GALNT3,GALNT14,GALNT18
ko00410	beta-Alanine metabolism	0.0904275585745306	-2.40320620655361	31	3	0.0125523012552301	239	6908	217,1962,2571	ALDH2,EHHADH,GAD1
hsa00410	beta-Alanine metabolism	0.0904275585745306	-2.40320620655361	31	3	0.0125523012552301	239	6908	217,1962,2571	ALDH2,EHHADH,GAD1
hsa05205	Proteoglycans in cancer	0.0932402097778735	-2.37257621494717	203	11	0.0460251046025105	239	6908	3480,3339,2247,287,3673,22808,857,4233,7422,5291,858	IGF1R,HSPG2,FGF2,ANK2,ITGA2,MRAS,CAV1,MET,VEGFA,PIK3CB,CAV2
ko05205	Proteoglycans in cancer	0.0932402097778735	-2.37257621494717	203	11	0.0460251046025105	239	6908	3480,3339,2247,287,3673,22808,857,4233,7422,5291,858	IGF1R,HSPG2,FGF2,ANK2,ITGA2,MRAS,CAV1,MET,VEGFA,PIK3CB,CAV2
ko01200	Carbon metabolism	0.0960609930513495	-2.34277194497514	113	7	0.0292887029288703	239	6908	84706,5096,1962,29968,26227,5095,3099	GPT2,PCCB,EHHADH,PSAT1,PHGDH,PCCA,HK2
hsa01200	Carbon metabolism	0.0960609930513495	-2.34277194497514	113	7	0.0292887029288703	239	6908	84706,5096,1962,29968,26227,5095,3099	GPT2,PCCB,EHHADH,PSAT1,PHGDH,PCCA,HK2
ko04724	Glutamatergic synapse	0.0995046672063944	-2.30755072932074	114	7	0.0292887029288703	239	6908	7220,6507,776,5337,23236,5330,2792	TRPC1,SLC1A3,CACNA1D,PLD1,PLCB1,PLCB2,GNGT1
hsa04724	Glutamatergic synapse	0.0995046672063944	-2.30755072932074	114	7	0.0292887029288703	239	6908	7220,6507,776,5337,23236,5330,2792	TRPC1,SLC1A3,CACNA1D,PLD1,PLCB1,PLCB2,GNGT1
ko04520	Adherens junction	0.107637849496978	-2.22898293198356	73	5	0.0209205020920502	239	6908	4008,2534,4233,3480,7048	LMO7,FYN,MET,IGF1R,TGFBR2
hsa01230	Biosynthesis of amino acids	0.107637849496978	-2.22898293198356	73	5	0.0209205020920502	239	6908	384,84706,29968,26227,4144	ARG2,GPT2,PSAT1,PHGDH,MAT2A
hsa04520	Adherens junction	0.107637849496978	-2.22898293198356	73	5	0.0209205020920502	239	6908	4008,2534,4233,3480,7048	LMO7,FYN,MET,IGF1R,TGFBR2
ko01230	Biosynthesis of amino acids	0.107637849496978	-2.22898293198356	73	5	0.0209205020920502	239	6908	384,84706,29968,26227,4144	ARG2,GPT2,PSAT1,PHGDH,MAT2A
hsa04910	Insulin signaling pathway	0.108308749731991	-2.22276933662286	139	8	0.0334728033472803	239	6908	8660,5599,3099,5584,5577,5106,5140,5291	IRS2,MAPK8,HK2,PRKCI,PRKAR2B,PCK2,PDE3B,PIK3CB
ko04910	Insulin signaling pathway	0.108308749731991	-2.22276933662286	139	8	0.0334728033472803	239	6908	8660,5599,3099,5584,5577,5106,5140,5291	IRS2,MAPK8,HK2,PRKCI,PRKAR2B,PCK2,PDE3B,PIK3CB
ko04713	Circadian entrainment	0.110468734093938	-2.20302274743818	95	6	0.0251046025104603	239	6908	4842,776,23236,5330,9252,2792	NOS1,CACNA1D,PLCB1,PLCB2,RPS6KA5,GNGT1
hsa04713	Circadian entrainment	0.110468734093938	-2.20302274743818	95	6	0.0251046025104603	239	6908	4842,776,23236,5330,9252,2792	NOS1,CACNA1D,PLCB1,PLCB2,RPS6KA5,GNGT1
ko05143	African trypanosomiasis	0.111818176207207	-2.19088115359349	34	3	0.0125523012552301	239	6908	3606,23236,5330	IL18,PLCB1,PLCB2
hsa05143	African trypanosomiasis	0.111818176207207	-2.19088115359349	34	3	0.0125523012552301	239	6908	3606,23236,5330	IL18,PLCB1,PLCB2
hsa04750	Inflammatory mediator regulation of TRP channels	0.123196995502453	-2.0939706153355	98	6	0.0251046025104603	239	6908	5599,23236,5330,5291,4914,3269	MAPK8,PLCB1,PLCB2,PIK3CB,NTRK1,HRH1
ko04750	Inflammatory mediator regulation of TRP channels	0.123196995502453	-2.0939706153355	98	6	0.0251046025104603	239	6908	5599,23236,5330,5291,4914,3269	MAPK8,PLCB1,PLCB2,PIK3CB,NTRK1,HRH1
ko03018	RNA degradation	0.127184594637406	-2.06211574675183	77	5	0.0209205020920502	239	6908	131870,54464,80336,84186,170506	NUDT16,XRN1,PABPC1L,ZCCHC7,DHX36
hsa03018	RNA degradation	0.127184594637406	-2.06211574675183	77	5	0.0209205020920502	239	6908	131870,54464,80336,84186,170506	NUDT16,XRN1,PABPC1L,ZCCHC7,DHX36
hsa01100	Metabolic pathways	0.131292385816295	-2.03032849009144	1214	49	0.205020920502092	239	6908	384,84706,349565,1962,6480,259230,4711,56922,9197,4842,26227,23175,84002,8706,6184,440,622,8833,5742,8309,5106,2762,374378,5330,4129,2571,11343,1608,4249,5096,217,29968,594,7378,5095,56895,2137,23236,79623,4144,10195,2591,23007,3099,339983,28999,138429,5337,874	ARG2,GPT2,NMNAT3,EHHADH,ST6GAL1,SGMS1,NDUFB5,MCCC1,SLC33A1,NOS1,PHGDH,LPIN1,B3GNT5,B3GALNT1,RPN1,ASNS,BDH1,GMPS,PTGS1,ACOX2,PCK2,GMDS,GALNT18,PLCB2,MAOB,GAD1,MGLL,DGKG,MGAT5,PCCB,ALDH2,PSAT1,BCKDHB,UPP1,PCCA,AGPAT4,EXTL3,PLCB1,GALNT14,MAT2A,ALG3,GALNT3,PLCH1,HK2,NAT8L,KLF15,PIP5KL1,PLD1,CBR3
hsa05100	Bacterial invasion of epithelial cells	0.132310622116653	-2.02260292297641	78	5	0.0209205020920502	239	6908	857,4233,5291,858,26084	CAV1,MET,PIK3CB,CAV2,ARHGEF26
ko05100	Bacterial invasion of epithelial cells	0.132310622116653	-2.02260292297641	78	5	0.0209205020920502	239	6908	857,4233,5291,858,26084	CAV1,MET,PIK3CB,CAV2,ARHGEF26
ko04723	Retrograde endocannabinoid signaling	0.136613586869486	-1.9905988721542	101	6	0.0251046025104603	239	6908	5599,776,23236,5330,11343,2792	MAPK8,CACNA1D,PLCB1,PLCB2,MGLL,GNGT1
hsa04723	Retrograde endocannabinoid signaling	0.136613586869486	-1.9905988721542	101	6	0.0251046025104603	239	6908	5599,776,23236,5330,11343,2792	MAPK8,CACNA1D,PLCB1,PLCB2,MGLL,GNGT1
hsa04110	Cell cycle	0.137551041015726	-1.98376022336883	124	7	0.0292887029288703	239	6908	545,902,10274,7029,4171,1021,4616	ATR,CCNH,STAG1,TFDP2,MCM2,CDK6,GADD45B
ko04110	Cell cycle	0.137551041015726	-1.98376022336883	124	7	0.0292887029288703	239	6908	545,902,10274,7029,4171,1021,4616	ATR,CCNH,STAG1,TFDP2,MCM2,CDK6,GADD45B
hsa04066	HIF-1 signaling pathway	0.145925261466068	-1.92466069610997	103	6	0.0251046025104603	239	6908	3480,7422,5291,7037,285,3099	IGF1R,VEGFA,PIK3CB,TFRC,ANGPT2,HK2
hsa05142	Chagas disease (American trypanosomiasis)	0.150687547879124	-1.89254680530294	104	6	0.0251046025104603	239	6908	5599,5522,23236,7048,5330,5291	MAPK8,PPP2R2C,PLCB1,TGFBR2,PLCB2,PIK3CB
ko05142	Chagas disease (American trypanosomiasis)	0.150687547879124	-1.89254680530294	104	6	0.0251046025104603	239	6908	5599,5522,23236,7048,5330,5291	MAPK8,PPP2R2C,PLCB1,TGFBR2,PLCB2,PIK3CB
ko00260	Glycine, serine and threonine metabolism	0.151165844061449	-1.88937773982023	39	3	0.0125523012552301	239	6908	29968,26227,4129	PSAT1,PHGDH,MAOB
hsa00260	Glycine, serine and threonine metabolism	0.151165844061449	-1.88937773982023	39	3	0.0125523012552301	239	6908	29968,26227,4129	PSAT1,PHGDH,MAOB
ko04024	cAMP signaling pathway	0.151254146180007	-1.88879376968654	199	10	0.0418410041841004	239	6908	5599,627,64411,483,5337,776,5144,9586,5140,5291	MAPK8,BDNF,ARAP3,ATP1B3,PLD1,CACNA1D,PDE4D,CREB5,PDE3B,PIK3CB
hsa04024	cAMP signaling pathway	0.151254146180007	-1.88879376968654	199	10	0.0418410041841004	239	6908	5599,627,64411,483,5337,776,5144,9586,5140,5291	MAPK8,BDNF,ARAP3,ATP1B3,PLD1,CACNA1D,PDE4D,CREB5,PDE3B,PIK3CB
hsa04150	mTOR signaling pathway	0.152940040447723	-1.87770932689818	60	4	0.0167364016736402	239	6908	6196,7422,5291,54541	RPS6KA2,VEGFA,PIK3CB,DDIT4
ko04150	mTOR signaling pathway	0.152940040447723	-1.87770932689818	60	4	0.0167364016736402	239	6908	6196,7422,5291,54541	RPS6KA2,VEGFA,PIK3CB,DDIT4
hsa04730	Long-term depression	0.152940040447723	-1.87770932689818	60	4	0.0167364016736402	239	6908	4842,3480,5330,23236	NOS1,IGF1R,PLCB2,PLCB1
ko04730	Long-term depression	0.152940040447723	-1.87770932689818	60	4	0.0167364016736402	239	6908	4842,3480,5330,23236	NOS1,IGF1R,PLCB2,PLCB1
ko00380	Tryptophan metabolism	0.159509870237078	-1.83564947630775	40	3	0.0125523012552301	239	6908	217,1962,4129	ALDH2,EHHADH,MAOB
hsa00380	Tryptophan metabolism	0.159509870237078	-1.83564947630775	40	3	0.0125523012552301	239	6908	217,1962,4129	ALDH2,EHHADH,MAOB
hsa00524	Butirosin and neomycin biosynthesis	0.161468460565614	-1.82344544600651	5	1	0.00418410041841004	239	6908	3099	HK2
ko00524	Butirosin and neomycin biosynthesis	0.161468460565614	-1.82344544600651	5	1	0.00418410041841004	239	6908	3099	HK2
hsa04611	Platelet activation	0.163347699856926	-1.81187422210597	130	7	0.0292887029288703	239	6908	5742,2534,23236,5330,5291,3673,5584	PTGS1,FYN,PLCB1,PLCB2,PIK3CB,ITGA2,PRKCI
ko05132	Salmonella infection	0.170651096470831	-1.76813417838882	85	5	0.0209205020920502	239	6908	5599,3606,5585,5217,7879	MAPK8,IL18,PKN1,PFN2,RAB7A
hsa05132	Salmonella infection	0.170651096470831	-1.76813417838882	85	5	0.0209205020920502	239	6908	5599,3606,5585,5217,7879	MAPK8,IL18,PKN1,PFN2,RAB7A
hsa04911	Insulin secretion	0.170651096470831	-1.76813417838882	85	5	0.0209205020920502	239	6908	483,9586,776,23236,5330	ATP1B3,CREB5,CACNA1D,PLCB1,PLCB2
ko04921	Oxytocin signaling pathway	0.176543631892282	-1.73418722697064	157	8	0.0334728033472803	239	6908	84254,57118,776,5330,23236,785,5291,4208	CAMKK1,CAMK1D,CACNA1D,PLCB2,PLCB1,CACNB4,PIK3CB,MEF2C
hsa04921	Oxytocin signaling pathway	0.176543631892282	-1.73418722697064	157	8	0.0334728033472803	239	6908	84254,57118,776,5330,23236,785,5291,4208	CAMKK1,CAMK1D,CACNA1D,PLCB2,PLCB1,CACNB4,PIK3CB,MEF2C
hsa04924	Renin secretion	0.179911254445619	-1.71529158052928	64	4	0.0167364016736402	239	6908	776,23236,5330,5140	CACNA1D,PLCB1,PLCB2,PDE3B
ko04924	Renin secretion	0.179911254445619	-1.71529158052928	64	4	0.0167364016736402	239	6908	776,23236,5330,5140	CACNA1D,PLCB1,PLCB2,PDE3B
hsa00340	Histidine metabolism	0.188183763061637	-1.67033633046435	23	2	0.00836820083682008	239	6908	217,4129	ALDH2,MAOB
hsa04964	Proximal tubule bicarbonate reclamation	0.188183763061637	-1.67033633046435	23	2	0.00836820083682008	239	6908	483,5106	ATP1B3,PCK2
ko04964	Proximal tubule bicarbonate reclamation	0.188183763061637	-1.67033633046435	23	2	0.00836820083682008	239	6908	483,5106	ATP1B3,PCK2
ko00340	Histidine metabolism	0.188183763061637	-1.67033633046435	23	2	0.00836820083682008	239	6908	217,4129	ALDH2,MAOB
hsa00750	Vitamin B6 metabolism	0.190500625991811	-1.65809979837453	6	1	0.00418410041841004	239	6908	29968	PSAT1
ko00750	Vitamin B6 metabolism	0.190500625991811	-1.65809979837453	6	1	0.00418410041841004	239	6908	29968	PSAT1
hsa01130	Biosynthesis of antibiotics	0.191050011928656	-1.65522004265188	210	10	0.0418410041841004	239	6908	384,5096,217,1962,29968,594,5095,3099,5106,26227	ARG2,PCCB,ALDH2,EHHADH,PSAT1,BCKDHB,PCCA,HK2,PCK2,PHGDH
ko04912	GnRH signaling pathway	0.206529907415742	-1.57731004696747	91	5	0.0209205020920502	239	6908	5599,5337,776,5330,23236	MAPK8,PLD1,CACNA1D,PLCB2,PLCB1
hsa04912	GnRH signaling pathway	0.206529907415742	-1.57731004696747	91	5	0.0209205020920502	239	6908	5599,5337,776,5330,23236	MAPK8,PLD1,CACNA1D,PLCB2,PLCB1
ko04961	Endocrine and other factor-regulated calcium reabsorption	0.2212754836489	-1.50834682139283	47	3	0.0125523012552301	239	6908	483,23236,5330	ATP1B3,PLCB1,PLCB2
hsa04961	Endocrine and other factor-regulated calcium reabsorption	0.2212754836489	-1.50834682139283	47	3	0.0125523012552301	239	6908	483,23236,5330	ATP1B3,PLCB1,PLCB2
ko04920	Adipocytokine signaling pathway	0.223001997342993	-1.50057455086709	70	4	0.0167364016736402	239	6908	8660,5599,5106,84254	IRS2,MAPK8,PCK2,CAMKK1
hsa04920	Adipocytokine signaling pathway	0.223001997342993	-1.50057455086709	70	4	0.0167364016736402	239	6908	8660,5599,5106,84254	IRS2,MAPK8,PCK2,CAMKK1
hsa04919	Thyroid hormone signaling pathway	0.223951394225513	-1.49632624073752	118	6	0.0251046025104603	239	6908	483,23236,5330,5291,117247,116931	ATP1B3,PLCB1,PLCB2,PIK3CB,SLC16A10,MED12L
hsa04141	Protein processing in endoplasmic reticulum	0.225765409566677	-1.48825882958304	168	8	0.0334728033472803	239	6908	5599,6184,29927,64215,7095,51726,6747,1649	MAPK8,RPN1,SEC61A1,DNAJC1,SEC62,DNAJB11,SSR3,DDIT3
ko04141	Protein processing in endoplasmic reticulum	0.225765409566677	-1.48825882958304	168	8	0.0334728033472803	239	6908	5599,6184,29927,64215,7095,51726,6747,1649	MAPK8,RPN1,SEC61A1,DNAJC1,SEC62,DNAJB11,SSR3,DDIT3
hsa04918	Thyroid hormone synthesis	0.230437158406916	-1.46777708535647	71	4	0.0167364016736402	239	6908	483,9586,23236,5330	ATP1B3,CREB5,PLCB1,PLCB2
ko04918	Thyroid hormone synthesis	0.230437158406916	-1.46777708535647	71	4	0.0167364016736402	239	6908	483,9586,23236,5330	ATP1B3,CREB5,PLCB1,PLCB2
ko00520	Amino sugar and nucleotide sugar metabolism	0.230476460535809	-1.46760654524929	48	3	0.0125523012552301	239	6908	2762,51700,3099	GMDS,CYB5R2,HK2
hsa00520	Amino sugar and nucleotide sugar metabolism	0.230476460535809	-1.46760654524929	48	3	0.0125523012552301	239	6908	2762,51700,3099	GMDS,CYB5R2,HK2
ko04320	Dorso-ventral axis formation	0.23948458400796	-1.42926623160175	27	2	0.00836820083682008	239	6908	22849,2113	CPEB3,ETS1
hsa04320	Dorso-ventral axis formation	0.23948458400796	-1.42926623160175	27	2	0.00836820083682008	239	6908	22849,2113	CPEB3,ETS1
hsa05144	Malaria	0.239747182435808	-1.42817031738021	49	3	0.0125523012552301	239	6908	3606,100528032,4233	IL18,KLRC4-KLRK1,MET
ko05144	Malaria	0.239747182435808	-1.42817031738021	49	3	0.0125523012552301	239	6908	3606,100528032,4233	IL18,KLRC4-KLRK1,MET
hsa05030	Cocaine addiction	0.239747182435808	-1.42817031738021	49	3	0.0125523012552301	239	6908	627,9586,4129	BDNF,CREB5,MAOB
ko05030	Cocaine addiction	0.239747182435808	-1.42817031738021	49	3	0.0125523012552301	239	6908	627,9586,4129	BDNF,CREB5,MAOB
hsa05220	Chronic myeloid leukemia	0.245486878144532	-1.40451178268915	73	4	0.0167364016736402	239	6908	7048,5291,1021,2122	TGFBR2,PIK3CB,CDK6,MECOM
ko05220	Chronic myeloid leukemia	0.245486878144532	-1.40451178268915	73	4	0.0167364016736402	239	6908	7048,5291,1021,2122	TGFBR2,PIK3CB,CDK6,MECOM
hsa04070	Phosphatidylinositol signaling system	0.25116563722888	-1.38164264821633	98	5	0.0209205020920502	239	6908	5330,23236,1608,5291,5305	PLCB2,PLCB1,DGKG,PIK3CB,PIP4K2A
ko04070	Phosphatidylinositol signaling system	0.25116563722888	-1.38164264821633	98	5	0.0209205020920502	239	6908	5330,23236,1608,5291,5305	PLCB2,PLCB1,DGKG,PIK3CB,PIP4K2A
hsa00630	Glyoxylate and dicarboxylate metabolism	0.252446118494656	-1.37655744513843	28	2	0.00836820083682008	239	6908	5096,5095	PCCB,PCCA
ko00630	Glyoxylate and dicarboxylate metabolism	0.252446118494656	-1.37655744513843	28	2	0.00836820083682008	239	6908	5096,5095	PCCB,PCCA
hsa04978	Mineral absorption	0.258466834969897	-1.35298789125334	51	3	0.0125523012552301	239	6908	483,1181,261729	ATP1B3,CLCN2,STEAP2
ko04978	Mineral absorption	0.258466834969897	-1.35298789125334	51	3	0.0125523012552301	239	6908	483,1181,261729	ATP1B3,CLCN2,STEAP2
hsa00310	Lysine degradation	0.267900701437416	-1.31713888415424	52	3	0.0125523012552301	239	6908	217,1962,5352	ALDH2,EHHADH,PLOD2
ko00310	Lysine degradation	0.267900701437416	-1.31713888415424	52	3	0.0125523012552301	239	6908	217,1962,5352	ALDH2,EHHADH,PLOD2
ko04922	Glucagon signaling pathway	0.27100598542932	-1.30561437189128	101	5	0.0209205020920502	239	6908	9586,5106,23236,5330,5140	CREB5,PCK2,PLCB1,PLCB2,PDE3B
hsa04922	Glucagon signaling pathway	0.27100598542932	-1.30561437189128	101	5	0.0209205020920502	239	6908	9586,5106,23236,5330,5140	CREB5,PCK2,PLCB1,PLCB2,PDE3B
hsa05166	HTLV-I infection	0.280490493380776	-1.27121544628436	258	11	0.0460251046025105	239	6908	5599,1958,1739,545,467,22808,8829,7048,2113,5291,4602	MAPK8,EGR1,DLG1,ATR,ATF3,MRAS,NRP1,TGFBR2,ETS1,PIK3CB,MYB
ko05166	HTLV-I infection	0.280490493380776	-1.27121544628436	258	11	0.0460251046025105	239	6908	5599,1958,1739,545,467,22808,8829,7048,2113,5291,4602	MAPK8,EGR1,DLG1,ATR,ATF3,MRAS,NRP1,TGFBR2,ETS1,PIK3CB,MYB
hsa03008	Ribosome biogenesis in eukaryotes	0.28396557466946	-1.25890226412078	78	4	0.0167364016736402	239	6908	166378,54464,51068,55341	SPATA5,XRN1,NMD3,LSG1
ko03008	Ribosome biogenesis in eukaryotes	0.28396557466946	-1.25890226412078	78	4	0.0167364016736402	239	6908	166378,54464,51068,55341	SPATA5,XRN1,NMD3,LSG1
hsa04390	Hippo signaling pathway	0.284063711713179	-1.25855672896248	154	7	0.0292887029288703	239	6908	2736,1490,5522,7048,25937,1739,5584	GLI2,CTGF,PPP2R2C,TGFBR2,WWTR1,DLG1,PRKCI
ko04390	Hippo signaling pathway	0.284063711713179	-1.25855672896248	154	7	0.0292887029288703	239	6908	2736,1490,5522,7048,25937,1739,5584	GLI2,CTGF,PPP2R2C,TGFBR2,WWTR1,DLG1,PRKCI
hsa04710	Circadian rhythm	0.291367510148199	-1.23316988715369	31	2	0.00836820083682008	239	6908	9575,406	CLOCK,ARNTL
ko04710	Circadian rhythm	0.291367510148199	-1.23316988715369	31	2	0.00836820083682008	239	6908	9575,406	CLOCK,ARNTL
hsa00072	Synthesis and degradation of ketone bodies	0.296956165983002	-1.21417074035463	10	1	0.00418410041841004	239	6908	622	BDH1
ko00072	Synthesis and degradation of ketone bodies	0.296956165983002	-1.21417074035463	10	1	0.00418410041841004	239	6908	622	BDH1
ko00051	Fructose and mannose metabolism	0.304301844678366	-1.18973516005892	32	2	0.00836820083682008	239	6908	2762,3099	GMDS,HK2
hsa00051	Fructose and mannose metabolism	0.304301844678366	-1.18973516005892	32	2	0.00836820083682008	239	6908	2762,3099	GMDS,HK2
hsa05223	Non-small cell lung cancer	0.305962872999341	-1.18429151445836	56	3	0.0125523012552301	239	6908	2272,5291,1021	FHIT,PIK3CB,CDK6
ko05223	Non-small cell lung cancer	0.305962872999341	-1.18429151445836	56	3	0.0125523012552301	239	6908	2272,5291,1021	FHIT,PIK3CB,CDK6
hsa00430	Taurine and hypotaurine metabolism	0.321315034692344	-1.13533322063937	11	1	0.00418410041841004	239	6908	2571	GAD1
ko00430	Taurine and hypotaurine metabolism	0.321315034692344	-1.13533322063937	11	1	0.00418410041841004	239	6908	2571	GAD1
ko04810	Regulation of actin cytoskeleton	0.322023138570263	-1.1331318771056	214	9	0.0376569037656904	239	6908	2247,3673,5062,22808,3687,5217,5291,9965,5305	FGF2,ITGA2,PAK2,MRAS,ITGAX,PFN2,PIK3CB,FGF19,PIP4K2A
hsa04810	Regulation of actin cytoskeleton	0.322023138570263	-1.1331318771056	214	9	0.0376569037656904	239	6908	2247,3673,5062,22808,3687,5217,5291,9965,5305	FGF2,ITGA2,PAK2,MRAS,ITGAX,PFN2,PIK3CB,FGF19,PIP4K2A
ko05410	Hypertrophic cardiomyopathy (HCM)	0.323266815827873	-1.12927724156065	83	4	0.0167364016736402	239	6908	7273,776,785,3673	TTN,CACNA1D,CACNB4,ITGA2
hsa05410	Hypertrophic cardiomyopathy (HCM)	0.323266815827873	-1.12927724156065	83	4	0.0167364016736402	239	6908	7273,776,785,3673	TTN,CACNA1D,CACNB4,ITGA2
hsa05416	Viral myocarditis	0.325096073135908	-1.12363453068737	58	3	0.0125523012552301	239	6908	857,1604,2534	CAV1,CD55,FYN
ko05020	Prion diseases	0.342798100770946	-1.07061363261532	35	2	0.00836820083682008	239	6908	2534,1958	FYN,EGR1
hsa05020	Prion diseases	0.342798100770946	-1.07061363261532	35	2	0.00836820083682008	239	6908	2534,1958	FYN,EGR1
hsa04012	ErbB signaling pathway	0.354984096547612	-1.03568228896763	87	4	0.0167364016736402	239	6908	5599,9542,5291,5062	MAPK8,NRG2,PIK3CB,PAK2
ko04640	Hematopoietic cell lineage	0.354984096547612	-1.03568228896763	87	4	0.0167364016736402	239	6908	1604,7037,3673,945	CD55,TFRC,ITGA2,CD33
ko04012	ErbB signaling pathway	0.354984096547612	-1.03568228896763	87	4	0.0167364016736402	239	6908	5599,9542,5291,5062	MAPK8,NRG2,PIK3CB,PAK2
hsa04640	Hematopoietic cell lineage	0.354984096547612	-1.03568228896763	87	4	0.0167364016736402	239	6908	1604,7037,3673,945	CD55,TFRC,ITGA2,CD33
hsa03030	DNA replication	0.355489342295227	-1.0342600096672	36	2	0.00836820083682008	239	6908	5984,4171	RFC4,MCM2
ko03030	DNA replication	0.355489342295227	-1.0342600096672	36	2	0.00836820083682008	239	6908	5984,4171	RFC4,MCM2
ko05210	Colorectal cancer	0.363320792302005	-1.01246910962276	62	3	0.0125523012552301	239	6908	5599,7048,5291	MAPK8,TGFBR2,PIK3CB
hsa05210	Colorectal cancer	0.363320792302005	-1.01246910962276	62	3	0.0125523012552301	239	6908	5599,7048,5291	MAPK8,TGFBR2,PIK3CB
hsa04550	Signaling pathways regulating pluripotency of stem cells	0.368229484999857	-0.999048934628139	142	6	0.0251046025104603	239	6908	1852,6498,3480,463,2247,5291	DUSP9,SKIL,IGF1R,ZFHX3,FGF2,PIK3CB
ko04550	Signaling pathways regulating pluripotency of stem cells	0.368229484999857	-0.999048934628139	142	6	0.0251046025104603	239	6908	1852,6498,3480,463,2247,5291	DUSP9,SKIL,IGF1R,ZFHX3,FGF2,PIK3CB
ko04970	Salivary secretion	0.370857845946365	-0.991936454366054	89	4	0.0167364016736402	239	6908	4842,483,23236,5330	NOS1,ATP1B3,PLCB1,PLCB2
ko05414	Dilated cardiomyopathy	0.370857845946365	-0.991936454366054	89	4	0.0167364016736402	239	6908	7273,776,785,3673	TTN,CACNA1D,CACNB4,ITGA2
hsa05414	Dilated cardiomyopathy	0.370857845946365	-0.991936454366054	89	4	0.0167364016736402	239	6908	7273,776,785,3673	TTN,CACNA1D,CACNB4,ITGA2
hsa04970	Salivary secretion	0.370857845946365	-0.991936454366054	89	4	0.0167364016736402	239	6908	4842,483,23236,5330	NOS1,ATP1B3,PLCB1,PLCB2
ko03015	mRNA surveillance pathway	0.386706883951064	-0.950088278740255	91	4	0.0167364016736402	239	6908	22916,80336,5522,5523	NCBP2,PABPC1L,PPP2R2C,PPP2R3A
hsa05032	Morphine addiction	0.386706883951064	-0.950088278740255	91	4	0.0167364016736402	239	6908	5144,5140,2792,50940	PDE4D,PDE3B,GNGT1,PDE11A
ko05032	Morphine addiction	0.386706883951064	-0.950088278740255	91	4	0.0167364016736402	239	6908	5144,5140,2792,50940	PDE4D,PDE3B,GNGT1,PDE11A
hsa03015	mRNA surveillance pathway	0.386706883951064	-0.950088278740255	91	4	0.0167364016736402	239	6908	22916,80336,5522,5523	NCBP2,PABPC1L,PPP2R2C,PPP2R3A
hsa00603	Glycosphingolipid biosynthesis - globo series	0.389462786472339	-0.942986960026912	14	1	0.00418410041841004	239	6908	8706	B3GALNT1
ko00603	Glycosphingolipid biosynthesis - globo series	0.389462786472339	-0.942986960026912	14	1	0.00418410041841004	239	6908	8706	B3GALNT1
ko05321	Inflammatory bowel disease (IBD)	0.391780240341442	-0.937054207766858	65	3	0.0125523012552301	239	6908	2625,3606,50615	GATA3,IL18,IL21R
hsa05214	Glioma	0.391780240341442	-0.937054207766858	65	3	0.0125523012552301	239	6908	3480,5291,1021	IGF1R,PIK3CB,CDK6
ko05214	Glioma	0.391780240341442	-0.937054207766858	65	3	0.0125523012552301	239	6908	3480,5291,1021	IGF1R,PIK3CB,CDK6
hsa05321	Inflammatory bowel disease (IBD)	0.391780240341442	-0.937054207766858	65	3	0.0125523012552301	239	6908	2625,3606,50615	GATA3,IL18,IL21R
ko04140	Regulation of autophagy	0.393001775668289	-0.933941148883162	39	2	0.00836820083682008	239	6908	9140,30849	ATG12,PIK3R4
ko04960	Aldosterone-regulated sodium reabsorption	0.393001775668289	-0.933941148883162	39	2	0.00836820083682008	239	6908	483,5291	ATP1B3,PIK3CB
hsa04140	Regulation of autophagy	0.393001775668289	-0.933941148883162	39	2	0.00836820083682008	239	6908	9140,30849	ATG12,PIK3R4
hsa04960	Aldosterone-regulated sodium reabsorption	0.393001775668289	-0.933941148883162	39	2	0.00836820083682008	239	6908	483,5291	ATP1B3,PIK3CB
hsa05161	Hepatitis B	0.39319775848152	-0.933442591433615	146	6	0.0251046025104603	239	6908	5599,1960,9586,3339,5291,1021	MAPK8,EGR3,CREB5,HSPG2,PIK3CB,CDK6
ko04932	Non-alcoholic fatty liver disease (NAFLD)	0.399440348034187	-0.917690841484868	147	6	0.0251046025104603	239	6908	8660,5599,22877,5291,1649,4711	IRS2,MAPK8,MLXIP,PIK3CB,DDIT3,NDUFB5
hsa04932	Non-alcoholic fatty liver disease (NAFLD)	0.399440348034187	-0.917690841484868	147	6	0.0251046025104603	239	6908	8660,5599,22877,5291,1649,4711	IRS2,MAPK8,MLXIP,PIK3CB,DDIT3,NDUFB5
hsa04720	Long-term potentiation	0.401200386232981	-0.913294260200451	66	3	0.0125523012552301	239	6908	6196,5330,23236	RPS6KA2,PLCB2,PLCB1
ko04720	Long-term potentiation	0.401200386232981	-0.913294260200451	66	3	0.0125523012552301	239	6908	6196,5330,23236	RPS6KA2,PLCB2,PLCB1
ko00620	Pyruvate metabolism	0.405290823325307	-0.903150387288615	40	2	0.00836820083682008	239	6908	217,5106	ALDH2,PCK2
hsa00620	Pyruvate metabolism	0.405290823325307	-0.903150387288615	40	2	0.00836820083682008	239	6908	217,5106	ALDH2,PCK2
ko00010	Glycolysis / Gluconeogenesis	0.410579830130832	-0.89018489851953	67	3	0.0125523012552301	239	6908	217,5106,3099	ALDH2,PCK2,HK2
hsa05031	Amphetamine addiction	0.410579830130832	-0.89018489851953	67	3	0.0125523012552301	239	6908	9586,776,4129	CREB5,CACNA1D,MAOB
hsa00010	Glycolysis / Gluconeogenesis	0.410579830130832	-0.89018489851953	67	3	0.0125523012552301	239	6908	217,5106,3099	ALDH2,PCK2,HK2
ko05031	Amphetamine addiction	0.410579830130832	-0.89018489851953	67	3	0.0125523012552301	239	6908	9586,776,4129	CREB5,CACNA1D,MAOB
hsa00604	Glycosphingolipid biosynthesis - ganglio series	0.410628785033874	-0.890065672047238	15	1	0.00418410041841004	239	6908	9197	SLC33A1
ko00604	Glycosphingolipid biosynthesis - ganglio series	0.410628785033874	-0.890065672047238	15	1	0.00418410041841004	239	6908	9197	SLC33A1
ko05219	Bladder cancer	0.417460032438654	-0.873566469959561	41	2	0.00836820083682008	239	6908	7422,9252	VEGFA,RPS6KA5
hsa05219	Bladder cancer	0.417460032438654	-0.873566469959561	41	2	0.00836820083682008	239	6908	7422,9252	VEGFA,RPS6KA5
hsa00564	Glycerophospholipid metabolism	0.418233983594293	-0.871714233705473	95	4	0.0167364016736402	239	6908	5337,1608,56895,23175	PLD1,DGKG,AGPAT4,LPIN1
ko04972	Pancreatic secretion	0.418233983594293	-0.871714233705473	95	4	0.0167364016736402	239	6908	7220,483,23236,5330	TRPC1,ATP1B3,PLCB1,PLCB2
hsa04972	Pancreatic secretion	0.418233983594293	-0.871714233705473	95	4	0.0167364016736402	239	6908	7220,483,23236,5330	TRPC1,ATP1B3,PLCB1,PLCB2
ko00564	Glycerophospholipid metabolism	0.418233983594293	-0.871714233705473	95	4	0.0167364016736402	239	6908	5337,1608,56895,23175	PLD1,DGKG,AGPAT4,LPIN1
ko04020	Calcium signaling pathway	0.425525716013428	-0.854429895630618	179	7	0.0292887029288703	239	6908	3363,4842,80228,776,23236,5330,3269	HTR7,NOS1,ORAI2,CACNA1D,PLCB1,PLCB2,HRH1
hsa04020	Calcium signaling pathway	0.425525716013428	-0.854429895630618	179	7	0.0292887029288703	239	6908	3363,4842,80228,776,5330,23236,3269	HTR7,NOS1,ORAI2,CACNA1D,PLCB2,PLCB1,HRH1
ko03320	PPAR signaling pathway	0.429199896926341	-0.845832508378603	69	3	0.0125523012552301	239	6908	8309,5106,1962	ACOX2,PCK2,EHHADH
hsa03320	PPAR signaling pathway	0.429199896926341	-0.845832508378603	69	3	0.0125523012552301	239	6908	8309,5106,1962	ACOX2,PCK2,EHHADH
ko04145	Phagosome	0.430579849891976	-0.842622490567213	152	6	0.0251046025104603	239	6908	4842,29927,7879,7037,3673,7277	NOS1,SEC61A1,RAB7A,TFRC,ITGA2,TUBA4A
hsa04145	Phagosome	0.430579849891976	-0.842622490567213	152	6	0.0251046025104603	239	6908	4842,29927,7879,7037,3673,7277	NOS1,SEC61A1,RAB7A,TFRC,ITGA2,TUBA4A
hsa04664	Fc epsilon RI signaling pathway	0.438432638701741	-0.824549096526177	70	3	0.0125523012552301	239	6908	5599,2534,5291	MAPK8,FYN,PIK3CB
ko04664	Fc epsilon RI signaling pathway	0.438432638701741	-0.824549096526177	70	3	0.0125523012552301	239	6908	5599,2534,5291	MAPK8,FYN,PIK3CB
hsa04940	Type I diabetes mellitus	0.44141381636143	-0.817772484422754	43	2	0.00836820083682008	239	6908	5799,2571	PTPRN2,GAD1
ko04940	Type I diabetes mellitus	0.44141381636143	-0.817772484422754	43	2	0.00836820083682008	239	6908	5799,2571	PTPRN2,GAD1
ko04915	Estrogen signaling pathway	0.449384645158216	-0.799876087241829	99	4	0.0167364016736402	239	6908	9586,23236,5330,5291	CREB5,PLCB1,PLCB2,PIK3CB
hsa04915	Estrogen signaling pathway	0.449384645158216	-0.799876087241829	99	4	0.0167364016736402	239	6908	9586,23236,5330,5291	CREB5,PLCB1,PLCB2,PIK3CB
ko00120	Primary bile acid biosynthesis	0.450793468242247	-0.796745986180034	17	1	0.00418410041841004	239	6908	8309	ACOX2
ko01210	2-Oxocarboxylic acid metabolism	0.450793468242247	-0.796745986180034	17	1	0.00418410041841004	239	6908	84706	GPT2
hsa00360	Phenylalanine metabolism	0.450793468242247	-0.796745986180034	17	1	0.00418410041841004	239	6908	4129	MAOB
hsa01210	2-Oxocarboxylic acid metabolism	0.450793468242247	-0.796745986180034	17	1	0.00418410041841004	239	6908	84706	GPT2
ko00360	Phenylalanine metabolism	0.450793468242247	-0.796745986180034	17	1	0.00418410041841004	239	6908	4129	MAOB
hsa00120	Primary bile acid biosynthesis	0.450793468242247	-0.796745986180034	17	1	0.00418410041841004	239	6908	8309	ACOX2
ko00071	Fatty acid degradation	0.453187259139893	-0.7914498633305	44	2	0.00836820083682008	239	6908	217,1962	ALDH2,EHHADH
hsa00071	Fatty acid degradation	0.453187259139893	-0.7914498633305	44	2	0.00836820083682008	239	6908	217,1962	ALDH2,EHHADH
ko05231	Choline metabolism in cancer	0.464768046347942	-0.766216822907578	101	4	0.0167364016736402	239	6908	5599,5337,1608,5291	MAPK8,PLD1,DGKG,PIK3CB
hsa05231	Choline metabolism in cancer	0.464768046347942	-0.766216822907578	101	4	0.0167364016736402	239	6908	5599,5337,1608,5291	MAPK8,PLD1,DGKG,PIK3CB
ko05016	Huntington's disease	0.470964762145547	-0.752972002742106	187	7	0.0292887029288703	239	6908	627,146754,9586,5330,23236,25981,4711	BDNF,DNAH2,CREB5,PLCB2,PLCB1,DNAH1,NDUFB5
hsa05016	Huntington's disease	0.470964762145547	-0.752972002742106	187	7	0.0292887029288703	239	6908	627,146754,9586,5330,23236,25981,4711	BDNF,DNAH2,CREB5,PLCB2,PLCB1,DNAH1,NDUFB5
hsa05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	0.474765001281252	-0.744935331513544	74	3	0.0125523012552301	239	6908	776,785,3673	CACNA1D,CACNB4,ITGA2
ko04260	Cardiac muscle contraction	0.474765001281252	-0.744935331513544	74	3	0.0125523012552301	239	6908	483,776,785	ATP1B3,CACNA1D,CACNB4
hsa04971	Gastric acid secretion	0.474765001281252	-0.744935331513544	74	3	0.0125523012552301	239	6908	483,23236,5330	ATP1B3,PLCB1,PLCB2
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	0.474765001281252	-0.744935331513544	74	3	0.0125523012552301	239	6908	776,785,3673	CACNA1D,CACNB4,ITGA2
hsa04260	Cardiac muscle contraction	0.474765001281252	-0.744935331513544	74	3	0.0125523012552301	239	6908	483,776,785	ATP1B3,CACNA1D,CACNB4
ko04971	Gastric acid secretion	0.474765001281252	-0.744935331513544	74	3	0.0125523012552301	239	6908	483,23236,5330	ATP1B3,PLCB1,PLCB2
hsa00983	Drug metabolism - other enzymes	0.476303368480268	-0.741700299018368	46	2	0.00836820083682008	239	6908	8833,7378	GMPS,UPP1
ko00983	Drug metabolism - other enzymes	0.476303368480268	-0.741700299018368	46	2	0.00836820083682008	239	6908	8833,7378	GMPS,UPP1
hsa04380	Osteoclast differentiation	0.476698445233614	-0.740871178296261	131	5	0.0209205020920502	239	6908	5599,2534,7048,5291,140885	MAPK8,FYN,TGFBR2,PIK3CB,SIRPA
ko04380	Osteoclast differentiation	0.476698445233614	-0.740871178296261	131	5	0.0209205020920502	239	6908	5599,2534,7048,5291,140885	MAPK8,FYN,TGFBR2,PIK3CB,SIRPA
ko04660	T cell receptor signaling pathway	0.487552108250199	-0.718358105538071	104	4	0.0167364016736402	239	6908	2534,5291,5062,1739	FYN,PIK3CB,PAK2,DLG1
hsa04660	T cell receptor signaling pathway	0.487552108250199	-0.718358105538071	104	4	0.0167364016736402	239	6908	2534,5291,5062,1739	FYN,PIK3CB,PAK2,DLG1
hsa03420	Nucleotide excision repair	0.487637941135754	-0.718182072392879	47	2	0.00836820083682008	239	6908	5984,902	RFC4,CCNH
ko03420	Nucleotide excision repair	0.487637941135754	-0.718182072392879	47	2	0.00836820083682008	239	6908	5984,902	RFC4,CCNH
hsa05010	Alzheimer's disease	0.491927716978593	-0.709423489993323	162	6	0.0251046025104603	239	6908	4842,776,5330,23236,23621,4711	NOS1,CACNA1D,PLCB2,PLCB1,BACE1,NDUFB5
ko05010	Alzheimer's disease	0.491927716978593	-0.709423489993323	162	6	0.0251046025104603	239	6908	4842,776,5330,23236,23621,4711	NOS1,CACNA1D,PLCB2,PLCB1,BACE1,NDUFB5
ko03013	RNA transport	0.515892709851587	-0.661856461764527	166	6	0.0251046025104603	239	6908	22916,8893,80336,8087,51068,1974	NCBP2,EIF2B5,PABPC1L,FXR1,NMD3,EIF4A2
hsa03013	RNA transport	0.515892709851587	-0.661856461764527	166	6	0.0251046025104603	239	6908	22916,8893,80336,8087,51068,1974	NCBP2,EIF2B5,PABPC1L,FXR1,NMD3,EIF4A2
ko04668	TNF signaling pathway	0.531877354110879	-0.631342353603886	110	4	0.0167364016736402	239	6908	5599,9586,9252,5291	MAPK8,CREB5,RPS6KA5,PIK3CB
hsa04668	TNF signaling pathway	0.531877354110879	-0.631342353603886	110	4	0.0167364016736402	239	6908	5599,9586,9252,5291	MAPK8,CREB5,RPS6KA5,PIK3CB
hsa03460	Fanconi anemia pathway	0.552328153181471	-0.5936129289373	53	2	0.00836820083682008	239	6908	55120,545	FANCL,ATR
ko03460	Fanconi anemia pathway	0.552328153181471	-0.5936129289373	53	2	0.00836820083682008	239	6908	55120,545	FANCL,ATR
ko03430	Mismatch repair	0.555653612741413	-0.587610177542386	23	1	0.00418410041841004	239	6908	5984	RFC4
hsa03430	Mismatch repair	0.555653612741413	-0.587610177542386	23	1	0.00418410041841004	239	6908	5984	RFC4
ko00230	Purine metabolism	0.562455153356756	-0.575443875447725	174	6	0.0251046025104603	239	6908	8833,131870,2272,5144,5140,50940	GMPS,NUDT16,FHIT,PDE4D,PDE3B,PDE11A
hsa00230	Purine metabolism	0.562455153356756	-0.575443875447725	174	6	0.0251046025104603	239	6908	8833,131870,2272,5144,5140,50940	GMPS,NUDT16,FHIT,PDE4D,PDE3B,PDE11A
hsa04210	Apoptosis	0.568507165754466	-0.56474136120174	85	3	0.0125523012552301	239	6908	5577,5291,4914	PRKAR2B,PIK3CB,NTRK1
ko04210	Apoptosis	0.568507165754466	-0.56474136120174	85	3	0.0125523012552301	239	6908	5577,5291,4914	PRKAR2B,PIK3CB,NTRK1
hsa05203	Viral carcinogenesis	0.56920035264078	-0.563522793229069	205	7	0.0292887029288703	239	6908	1960,9586,5366,5291,1021,5922,1739	EGR3,CREB5,PMAIP1,PIK3CB,CDK6,RASA2,DLG1
ko05203	Viral carcinogenesis	0.56920035264078	-0.563522793229069	205	7	0.0292887029288703	239	6908	1960,9586,5366,5291,1021,5922,1739	EGR3,CREB5,PMAIP1,PIK3CB,CDK6,RASA2,DLG1
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	0.571078273102572	-0.560228997980777	24	1	0.00418410041841004	239	6908	2137	EXTL3
hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	0.571078273102572	-0.560228997980777	24	1	0.00418410041841004	239	6908	2137	EXTL3
ko05130	Pathogenic Escherichia coli infection	0.572580164580975	-0.557602527887441	55	2	0.00836820083682008	239	6908	2534,7277	FYN,TUBA4A
hsa05130	Pathogenic Escherichia coli infection	0.572580164580975	-0.557602527887441	55	2	0.00836820083682008	239	6908	2534,7277	FYN,TUBA4A
hsa05145	Toxoplasmosis	0.587890179655453	-0.531215117820514	118	4	0.0167364016736402	239	6908	10319,5599,5291,3914	LAMC3,MAPK8,PIK3CB,LAMB3
ko05145	Toxoplasmosis	0.587890179655453	-0.531215117820514	118	4	0.0167364016736402	239	6908	10319,5599,5291,3914	LAMC3,MAPK8,PIK3CB,LAMB3
hsa04621	NOD-like receptor signaling pathway	0.592161372856451	-0.523976091959295	57	2	0.00836820083682008	239	6908	5599,3606	MAPK8,IL18
hsa05221	Acute myeloid leukemia	0.592161372856451	-0.523976091959295	57	2	0.00836820083682008	239	6908	5292,5291	PIM1,PIK3CB
ko05221	Acute myeloid leukemia	0.592161372856451	-0.523976091959295	57	2	0.00836820083682008	239	6908	5292,5291	PIM1,PIK3CB
ko04621	NOD-like receptor signaling pathway	0.592161372856451	-0.523976091959295	57	2	0.00836820083682008	239	6908	5599,3606	MAPK8,IL18
hsa04727	GABAergic synapse	0.592241173537605	-0.523841339325542	88	3	0.0125523012552301	239	6908	776,2571,2792	CACNA1D,GAD1,GNGT1
ko04727	GABAergic synapse	0.592241173537605	-0.523841339325542	88	3	0.0125523012552301	239	6908	776,2571,2792	CACNA1D,GAD1,GNGT1
hsa04540	Gap junction	0.592241173537605	-0.523841339325542	88	3	0.0125523012552301	239	6908	5330,23236,7277	PLCB2,PLCB1,TUBA4A
ko04540	Gap junction	0.592241173537605	-0.523841339325542	88	3	0.0125523012552301	239	6908	5330,23236,7277	PLCB2,PLCB1,TUBA4A
hsa05215	Prostate cancer	0.59996384776863	-0.510885879300269	89	3	0.0125523012552301	239	6908	9586,3480,5291	CREB5,IGF1R,PIK3CB
ko05215	Prostate cancer	0.59996384776863	-0.510885879300269	89	3	0.0125523012552301	239	6908	9586,3480,5291	CREB5,IGF1R,PIK3CB
hsa00601	Glycosphingolipid biosynthesis - lacto and neolacto series	0.600346129145635	-0.510248908189002	26	1	0.00418410041841004	239	6908	84002	B3GNT5
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	0.600346129145635	-0.510248908189002	26	1	0.00418410041841004	239	6908	84002	B3GNT5
hsa04270	Vascular smooth muscle contraction	0.601274756995512	-0.508703282533757	120	4	0.0167364016736402	239	6908	10335,776,5330,23236	MRVI1,CACNA1D,PLCB2,PLCB1
ko04270	Vascular smooth muscle contraction	0.601274756995512	-0.508703282533757	120	4	0.0167364016736402	239	6908	10335,776,5330,23236	MRVI1,CACNA1D,PLCB2,PLCB1
hsa00053	Ascorbate and aldarate metabolism	0.614225419343952	-0.487393285729628	27	1	0.00418410041841004	239	6908	217	ALDH2
ko00053	Ascorbate and aldarate metabolism	0.614225419343952	-0.487393285729628	27	1	0.00418410041841004	239	6908	217	ALDH2
ko04666	Fc gamma R-mediated phagocytosis	0.622553560973821	-0.473925612619638	92	3	0.0125523012552301	239	6908	5337,50807,5291	PLD1,ASAP1,PIK3CB
hsa04666	Fc gamma R-mediated phagocytosis	0.622553560973821	-0.473925612619638	92	3	0.0125523012552301	239	6908	5337,50807,5291	PLD1,ASAP1,PIK3CB
ko04744	Phototransduction	0.627624652704597	-0.465812977976002	28	1	0.00418410041841004	239	6908	2792	GNGT1
hsa04744	Phototransduction	0.627624652704597	-0.465812977976002	28	1	0.00418410041841004	239	6908	2792	GNGT1
ko04370	VEGF signaling pathway	0.629303763305189	-0.463141208322224	61	2	0.00836820083682008	239	6908	7422,5291	VEGFA,PIK3CB
hsa04370	VEGF signaling pathway	0.629303763305189	-0.463141208322224	61	2	0.00836820083682008	239	6908	7422,5291	VEGFA,PIK3CB
hsa00590	Arachidonic acid metabolism	0.638169862339555	-0.449150789161907	62	2	0.00836820083682008	239	6908	5742,874	PTGS1,CBR3
ko00590	Arachidonic acid metabolism	0.638169862339555	-0.449150789161907	62	2	0.00836820083682008	239	6908	5742,874	PTGS1,CBR3
ko05216	Thyroid cancer	0.640560366075183	-0.445411913725504	29	1	0.00418410041841004	239	6908	4914	NTRK1
ko00760	Nicotinate and nicotinamide metabolism	0.640560366075183	-0.445411913725504	29	1	0.00418410041841004	239	6908	349565	NMNAT3
hsa00760	Nicotinate and nicotinamide metabolism	0.640560366075183	-0.445411913725504	29	1	0.00418410041841004	239	6908	349565	NMNAT3
hsa05216	Thyroid cancer	0.640560366075183	-0.445411913725504	29	1	0.00418410041841004	239	6908	4914	NTRK1
ko04721	Synaptic vesicle cycle	0.646869342251672	-0.43561094884426	63	2	0.00836820083682008	239	6908	6812,6857	STXBP1,SYT1
hsa04721	Synaptic vesicle cycle	0.646869342251672	-0.43561094884426	63	2	0.00836820083682008	239	6908	6812,6857	STXBP1,SYT1
ko00052	Galactose metabolism	0.653048528964795	-0.426103835522517	30	1	0.00418410041841004	239	6908	3099	HK2
ko00020	Citrate cycle (TCA cycle)	0.653048528964795	-0.426103835522517	30	1	0.00418410041841004	239	6908	5106	PCK2
hsa00052	Galactose metabolism	0.653048528964795	-0.426103835522517	30	1	0.00418410041841004	239	6908	3099	HK2
hsa00020	Citrate cycle (TCA cycle)	0.653048528964795	-0.426103835522517	30	1	0.00418410041841004	239	6908	5106	PCK2
hsa05131	Shigellosis	0.655403068974817	-0.422504860130252	64	2	0.00836820083682008	239	6908	5599,5217	MAPK8,PFN2
ko00514	Other types of O-glycan biosynthesis	0.665104562926652	-0.407811013203114	31	1	0.00418410041841004	239	6908	6480	ST6GAL1
hsa00514	Other types of O-glycan biosynthesis	0.665104562926652	-0.407811013203114	31	1	0.00418410041841004	239	6908	6480	ST6GAL1
hsa05120	Epithelial cell signaling in Helicobacter pylori infection	0.687902416701659	-0.374108287297946	68	2	0.00836820083682008	239	6908	5599,4233	MAPK8,MET
ko05120	Epithelial cell signaling in Helicobacter pylori infection	0.687902416701659	-0.374108287297946	68	2	0.00836820083682008	239	6908	5599,4233	MAPK8,MET
hsa04622	RIG-I-like receptor signaling pathway	0.703189357660442	-0.352129066883199	70	2	0.00836820083682008	239	6908	9140,5599	ATG12,MAPK8
ko04622	RIG-I-like receptor signaling pathway	0.703189357660442	-0.352129066883199	70	2	0.00836820083682008	239	6908	9140,5599	ATG12,MAPK8
ko05206	MicroRNAs in cancer	0.706902507821611	-0.346862518178743	297	9	0.0376569037656904	239	6908	8660,6541,4194,5292,4233,7422,9252,1021,54541	IRS2,SLC7A1,MDM4,PIM1,MET,VEGFA,RPS6KA5,CDK6,DDIT4
hsa05206	MicroRNAs in cancer	0.706902507821611	-0.346862518178743	297	9	0.0376569037656904	239	6908	8660,6541,4194,5292,4233,7422,9252,1021,54541	IRS2,SLC7A1,MDM4,PIM1,MET,VEGFA,RPS6KA5,CDK6,DDIT4
ko00350	Tyrosine metabolism	0.709297693249276	-0.343479962930411	35	1	0.00418410041841004	239	6908	4129	MAOB
hsa00350	Tyrosine metabolism	0.709297693249276	-0.343479962930411	35	1	0.00418410041841004	239	6908	4129	MAOB
hsa04530	Tight junction	0.709383057174091	-0.343359620245995	138	4	0.0167364016736402	239	6908	22808,5522,60412,5584	MRAS,PPP2R2C,EXOC4,PRKCI
ko04530	Tight junction	0.709383057174091	-0.343359620245995	138	4	0.0167364016736402	239	6908	22808,5522,60412,5584	MRAS,PPP2R2C,EXOC4,PRKCI
hsa04976	Bile secretion	0.710597486581726	-0.341649132438159	71	2	0.00836820083682008	239	6908	483,57552	ATP1B3,NCEH1
ko04976	Bile secretion	0.710597486581726	-0.341649132438159	71	2	0.00836820083682008	239	6908	483,57552	ATP1B3,NCEH1
ko04620	Toll-like receptor signaling pathway	0.71622909164322	-0.333755202802344	106	3	0.0125523012552301	239	6908	5599,6696,5291	MAPK8,SPP1,PIK3CB
hsa04620	Toll-like receptor signaling pathway	0.71622909164322	-0.333755202802344	106	3	0.0125523012552301	239	6908	5599,6696,5291	MAPK8,SPP1,PIK3CB
hsa04917	Prolactin signaling pathway	0.717850979571951	-0.331493280817945	72	2	0.00836820083682008	239	6908	5599,5291	MAPK8,PIK3CB
ko04917	Prolactin signaling pathway	0.717850979571951	-0.331493280817945	72	2	0.00836820083682008	239	6908	5599,5291	MAPK8,PIK3CB
ko00040	Pentose and glucuronate interconversions	0.719406503276998	-0.32932870789909	36	1	0.00418410041841004	239	6908	217	ALDH2
hsa00040	Pentose and glucuronate interconversions	0.719406503276998	-0.32932870789909	36	1	0.00418410041841004	239	6908	217	ALDH2
hsa00270	Cysteine and methionine metabolism	0.729165211906978	-0.31585494451947	37	1	0.00418410041841004	239	6908	4144	MAT2A
ko00270	Cysteine and methionine metabolism	0.729165211906978	-0.31585494451947	37	1	0.00418410041841004	239	6908	4144	MAT2A
ko04514	Cell adhesion molecules (CAMs)	0.730280801742344	-0.314326158881342	142	4	0.0167364016736402	239	6908	26047,57555,9379,10666	CNTNAP2,NLGN2,NRXN2,CD226
hsa04514	Cell adhesion molecules (CAMs)	0.730280801742344	-0.314326158881342	142	4	0.0167364016736402	239	6908	26047,57555,9379,10666	CNTNAP2,NLGN2,NRXN2,CD226
ko05152	Tuberculosis	0.739480060549292	-0.30180796061699	177	5	0.0209205020920502	239	6908	5599,3606,3687,7879,1054	MAPK8,IL18,ITGAX,RAB7A,CEBPG
hsa05152	Tuberculosis	0.739480060549292	-0.30180796061699	177	5	0.0209205020920502	239	6908	5599,3606,3687,7879,1054	MAPK8,IL18,ITGAX,RAB7A,CEBPG
ko05034	Alcoholism	0.748356993977545	-0.289875150186358	179	5	0.0209205020920502	239	6908	627,9586,4129,84254,2792	BDNF,CREB5,MAOB,CAMKK1,GNGT1
hsa05034	Alcoholism	0.748356993977545	-0.289875150186358	179	5	0.0209205020920502	239	6908	627,9586,4129,84254,2792	BDNF,CREB5,MAOB,CAMKK1,GNGT1
hsa04114	Oocyte meiosis	0.750488488563653	-0.28703096638248	112	3	0.0125523012552301	239	6908	22849,6196,3480	CPEB3,RPS6KA2,IGF1R
ko04114	Oocyte meiosis	0.750488488563653	-0.28703096638248	112	3	0.0125523012552301	239	6908	22849,6196,3480	CPEB3,RPS6KA2,IGF1R
ko04062	Chemokine signaling pathway	0.781635930631866	-0.246366208696228	187	5	0.0209205020920502	239	6908	58191,5330,23236,5291,2792	CXCL16,PLCB2,PLCB1,PIK3CB,GNGT1
hsa04062	Chemokine signaling pathway	0.781635930631866	-0.246366208696228	187	5	0.0209205020920502	239	6908	58191,5330,23236,5291,2792	CXCL16,PLCB2,PLCB1,PIK3CB,GNGT1
hsa04146	Peroxisome	0.787979753505623	-0.238282882975126	83	2	0.00836820083682008	239	6908	8309,1962	ACOX2,EHHADH
ko04146	Peroxisome	0.787979753505623	-0.238282882975126	83	2	0.00836820083682008	239	6908	8309,1962	ACOX2,EHHADH
hsa02010	ABC transporters	0.788637193979767	-0.237448894080994	44	1	0.00418410041841004	239	6908	10057	ABCC5
ko02010	ABC transporters	0.788637193979767	-0.237448894080994	44	1	0.00418410041841004	239	6908	10057	ABCC5
ko04962	Vasopressin-regulated water reabsorption	0.788637193979767	-0.237448894080994	44	1	0.00418410041841004	239	6908	9586	CREB5
hsa00970	Aminoacyl-tRNA biosynthesis	0.788637193979767	-0.237448894080994	44	1	0.00418410041841004	239	6908	833	CARS
hsa04962	Vasopressin-regulated water reabsorption	0.788637193979767	-0.237448894080994	44	1	0.00418410041841004	239	6908	9586	CREB5
ko00970	Aminoacyl-tRNA biosynthesis	0.788637193979767	-0.237448894080994	44	1	0.00418410041841004	239	6908	833	CARS
ko00565	Ether lipid metabolism	0.795996708936914	-0.228160227647665	45	1	0.00418410041841004	239	6908	5337	PLD1
hsa00565	Ether lipid metabolism	0.795996708936914	-0.228160227647665	45	1	0.00418410041841004	239	6908	5337	PLD1
hsa03022	Basal transcription factors	0.795996708936914	-0.228160227647665	45	1	0.00418410041841004	239	6908	902	CCNH
ko03022	Basal transcription factors	0.795996708936914	-0.228160227647665	45	1	0.00418410041841004	239	6908	902	CCNH
ko04630	Jak-STAT signaling pathway	0.802691345526311	-0.21978501560659	158	4	0.0167364016736402	239	6908	53833,5292,50615,5291	IL20RB,PIM1,IL21R,PIK3CB
hsa04630	Jak-STAT signaling pathway	0.802691345526311	-0.21978501560659	158	4	0.0167364016736402	239	6908	53833,5292,50615,5291	IL20RB,PIM1,IL21R,PIK3CB
ko00600	Sphingolipid metabolism	0.809958898089347	-0.210771775702698	47	1	0.00418410041841004	239	6908	259230	SGMS1
hsa00600	Sphingolipid metabolism	0.809958898089347	-0.210771775702698	47	1	0.00418410041841004	239	6908	259230	SGMS1
hsa01212	Fatty acid metabolism	0.816578898579465	-0.202631741014095	48	1	0.00418410041841004	239	6908	1962	EHHADH
ko01212	Fatty acid metabolism	0.816578898579465	-0.202631741014095	48	1	0.00418410041841004	239	6908	1962	EHHADH
hsa04060	Cytokine-cytokine receptor interaction	0.818187140970925	-0.200664189852182	265	7	0.0292887029288703	239	6908	58191,53833,3606,4233,7422,50615,7048	CXCL16,IL20RB,IL18,MET,VEGFA,IL21R,TGFBR2
ko04060	Cytokine-cytokine receptor interaction	0.818187140970925	-0.200664189852182	265	7	0.0292887029288703	239	6908	58191,53833,3606,4233,7422,50615,7048	CXCL16,IL20RB,IL18,MET,VEGFA,IL21R,TGFBR2
hsa05323	Rheumatoid arthritis	0.819402929679666	-0.199179338479534	89	2	0.00836820083682008	239	6908	3606,7422	IL18,VEGFA
ko05323	Rheumatoid arthritis	0.819402929679666	-0.199179338479534	89	2	0.00836820083682008	239	6908	3606,7422	IL18,VEGFA
hsa04913	Ovarian steroidogenesis	0.829137815033311	-0.187368895162618	50	1	0.00418410041841004	239	6908	3480	IGF1R
ko04913	Ovarian steroidogenesis	0.829137815033311	-0.187368895162618	50	1	0.00418410041841004	239	6908	3480	IGF1R
hsa04340	Hedgehog signaling pathway	0.835092329803139	-0.180212985629666	51	1	0.00418410041841004	239	6908	2736	GLI2
ko04340	Hedgehog signaling pathway	0.835092329803139	-0.180212985629666	51	1	0.00418410041841004	239	6908	2736	GLI2
hsa05014	Amyotrophic lateral sclerosis (ALS)	0.835092329803139	-0.180212985629666	51	1	0.00418410041841004	239	6908	4842	NOS1
ko04742	Taste transduction	0.835092329803139	-0.180212985629666	51	1	0.00418410041841004	239	6908	5330	PLCB2
ko05014	Amyotrophic lateral sclerosis (ALS)	0.835092329803139	-0.180212985629666	51	1	0.00418410041841004	239	6908	4842	NOS1
hsa04742	Taste transduction	0.835092329803139	-0.180212985629666	51	1	0.00418410041841004	239	6908	5330	PLCB2
hsa05213	Endometrial cancer	0.84084016895969	-0.173353685870168	52	1	0.00418410041841004	239	6908	5291	PIK3CB
ko05213	Endometrial cancer	0.84084016895969	-0.173353685870168	52	1	0.00418410041841004	239	6908	5291	PIK3CB
ko05160	Hepatitis C	0.844996590032038	-0.16842268709815	133	3	0.0125523012552301	239	6908	5599,5522,5291	MAPK8,PPP2R2C,PIK3CB
hsa05160	Hepatitis C	0.844996590032038	-0.16842268709815	133	3	0.0125523012552301	239	6908	5599,5522,5291	MAPK8,PPP2R2C,PIK3CB
ko05110	Vibrio cholerae infection	0.84638847696913	-0.166776832137682	53	1	0.00418410041841004	239	6908	29927	SEC61A1
hsa05110	Vibrio cholerae infection	0.84638847696913	-0.166776832137682	53	1	0.00418410041841004	239	6908	29927	SEC61A1
ko05162	Measles	0.8486070563894	-0.164159030918058	134	3	0.0125523012552301	239	6908	2534,5291,1021	FYN,PIK3CB,CDK6
hsa05162	Measles	0.8486070563894	-0.164159030918058	134	3	0.0125523012552301	239	6908	2534,5291,1021	FYN,PIK3CB,CDK6
hsa04650	Natural killer cell mediated cytotoxicity	0.8486070563894	-0.164159030918058	134	3	0.0125523012552301	239	6908	100528032,2534,5291	KLRC4-KLRK1,FYN,PIK3CB
ko04650	Natural killer cell mediated cytotoxicity	0.8486070563894	-0.164159030918058	134	3	0.0125523012552301	239	6908	100528032,2534,5291	KLRC4-KLRK1,FYN,PIK3CB
hsa05134	Legionellosis	0.856913855712299	-0.154417883858727	55	1	0.00418410041841004	239	6908	3606	IL18
ko05217	Basal cell carcinoma	0.856913855712299	-0.154417883858727	55	1	0.00418410041841004	239	6908	2736	GLI2
ko05134	Legionellosis	0.856913855712299	-0.154417883858727	55	1	0.00418410041841004	239	6908	3606	IL18
hsa05217	Basal cell carcinoma	0.856913855712299	-0.154417883858727	55	1	0.00418410041841004	239	6908	2736	GLI2
ko00500	Starch and sucrose metabolism	0.861904018931381	-0.14861136146533	56	1	0.00418410041841004	239	6908	3099	HK2
hsa00500	Starch and sucrose metabolism	0.861904018931381	-0.14861136146533	56	1	0.00418410041841004	239	6908	3099	HK2
hsa04916	Melanogenesis	0.866376402816021	-0.143435819566513	100	2	0.00836820083682008	239	6908	5330,23236	PLCB2,PLCB1
ko04916	Melanogenesis	0.866376402816021	-0.143435819566513	100	2	0.00836820083682008	239	6908	5330,23236	PLCB2,PLCB1
ko00140	Steroid hormone biosynthesis	0.87137035070639	-0.137688190772778	58	1	0.00418410041841004	239	6908	6820	SULT2B1
hsa00140	Steroid hormone biosynthesis	0.87137035070639	-0.137688190772778	58	1	0.00418410041841004	239	6908	6820	SULT2B1
hsa04623	Cytosolic DNA-sensing pathway	0.892303625583689	-0.113948816895124	63	1	0.00418410041841004	239	6908	3606	IL18
ko04623	Cytosolic DNA-sensing pathway	0.892303625583689	-0.113948816895124	63	1	0.00418410041841004	239	6908	3606	IL18
ko00982	Drug metabolism - cytochrome P450	0.90984211759146	-0.0944841916758547	68	1	0.00418410041841004	239	6908	4129	MAOB
hsa00982	Drug metabolism - cytochrome P450	0.90984211759146	-0.0944841916758547	68	1	0.00418410041841004	239	6908	4129	MAOB
ko04610	Complement and coagulation cascades	0.912992371075944	-0.0910277543082308	69	1	0.00418410041841004	239	6908	1604	CD55
hsa04610	Complement and coagulation cascades	0.912992371075944	-0.0910277543082308	69	1	0.00418410041841004	239	6908	1604	CD55
hsa04662	B cell receptor signaling pathway	0.92180041852707	-0.0814265446634283	72	1	0.00418410041841004	239	6908	5291	PIK3CB
ko04662	B cell receptor signaling pathway	0.92180041852707	-0.0814265446634283	72	1	0.00418410041841004	239	6908	5291	PIK3CB
hsa00980	Metabolism of xenobiotics by cytochrome P450	0.927173240370988	-0.0756148480601001	74	1	0.00418410041841004	239	6908	874	CBR3
ko00980	Metabolism of xenobiotics by cytochrome P450	0.927173240370988	-0.0756148480601001	74	1	0.00418410041841004	239	6908	874	CBR3
ko05133	Pertussis	0.929720152220966	-0.0728716497081716	75	1	0.00418410041841004	239	6908	5599	MAPK8
hsa05133	Pertussis	0.929720152220966	-0.0728716497081716	75	1	0.00418410041841004	239	6908	5599	MAPK8
hsa05164	Influenza A	0.944148227084992	-0.057472104945868	174	3	0.0125523012552301	239	6908	5599,3606,5291	MAPK8,IL18,PIK3CB
ko05164	Influenza A	0.944148227084992	-0.057472104945868	174	3	0.0125523012552301	239	6908	5599,3606,5291	MAPK8,IL18,PIK3CB
ko03040	Spliceosome	0.946655139837655	-0.0548204127969552	132	2	0.00836820083682008	239	6908	22916,23350	NCBP2,U2SURP
hsa03040	Spliceosome	0.946655139837655	-0.0548204127969552	132	2	0.00836820083682008	239	6908	22916,23350	NCBP2,U2SURP
hsa03010	Ribosome	0.9482071787701	-0.0531822575977244	133	2	0.00836820083682008	239	6908	6165,11222	RPL35A,MRPL3
ko03010	Ribosome	0.9482071787701	-0.0531822575977244	133	2	0.00836820083682008	239	6908	6165,11222	RPL35A,MRPL3
ko04350	TGF-beta signaling pathway	0.948998199475661	-0.0523483776599298	84	1	0.00418410041841004	239	6908	7048	TGFBR2
hsa04350	TGF-beta signaling pathway	0.948998199475661	-0.0523483776599298	84	1	0.00418410041841004	239	6908	7048	TGFBR2
ko04120	Ubiquitin mediated proteolysis	0.953996728028553	-0.0470950372791947	137	2	0.00836820083682008	239	6908	7328,55120	UBE2H,FANCL
hsa04120	Ubiquitin mediated proteolysis	0.953996728028553	-0.0470950372791947	137	2	0.00836820083682008	239	6908	7328,55120	UBE2H,FANCL
ko05168	Herpes simplex infection	0.957085921550248	-0.0438621093751949	184	3	0.0125523012552301	239	6908	5599,9575,406	MAPK8,CLOCK,ARNTL
hsa05168	Herpes simplex infection	0.957085921550248	-0.0438621093751949	184	3	0.0125523012552301	239	6908	5599,9575,406	MAPK8,CLOCK,ARNTL
hsa04064	NF-kappa B signaling pathway	0.960266730989317	-0.040544188331429	91	1	0.00418410041841004	239	6908	4616	GADD45B
hsa00240	Pyrimidine metabolism	0.975026408557528	-0.0252907226510724	104	1	0.00418410041841004	239	6908	7378	UPP1
ko00240	Pyrimidine metabolism	0.975026408557528	-0.0252907226510724	104	1	0.00418410041841004	239	6908	7378	UPP1
ko04670	Leukocyte transendothelial migration	0.984869432558956	-0.0152462023740512	118	1	0.00418410041841004	239	6908	5291	PIK3CB
hsa04670	Leukocyte transendothelial migration	0.984869432558956	-0.0152462023740512	118	1	0.00418410041841004	239	6908	5291	PIK3CB
hsa00190	Oxidative phosphorylation	0.985915918415983	-0.0141842034558381	120	1	0.00418410041841004	239	6908	4711	NDUFB5
ko00190	Oxidative phosphorylation	0.985915918415983	-0.0141842034558381	120	1	0.00418410041841004	239	6908	4711	NDUFB5
hsa05012	Parkinson's disease	0.989801347005792	-0.0102510155784393	129	1	0.00418410041841004	239	6908	4711	NDUFB5
ko05169	Epstein-Barr virus infection	0.99318639733906	-0.00683692123424111	199	2	0.00836820083682008	239	6908	5599,5291	MAPK8,PIK3CB
hsa05169	Epstein-Barr virus infection	0.99318639733906	-0.00683692123424111	199	2	0.00836820083682008	239	6908	5599,5291	MAPK8,PIK3CB
ko04080	Neuroactive ligand-receptor interaction	0.996848293544807	-0.00315668354227863	276	3	0.0125523012552301	239	6908	3363,3269,2894	HTR7,HRH1,GRID1
hsa04080	Neuroactive ligand-receptor interaction	0.996848293544807	-0.00315668354227863	276	3	0.0125523012552301	239	6908	3363,3269,2894	HTR7,HRH1,GRID1
hsa00300	Lysine biosynthesis	0.999999999996328	-3.67194556011308e-12	2	0	0	239	6908
ko00300	Lysine biosynthesis	0.999999999996328	-3.67194556011308e-12	2	0	0	239	6908
hsa00460	Cyanoamino acid metabolism	0.999999999997456	-2.54409921341875e-12	7	0	0	239	6908
ko00460	Cyanoamino acid metabolism	0.999999999997456	-2.54409921341875e-12	7	0	0	239	6908
hsa00770	Pantothenate and CoA biosynthesis	0.999999999997967	-2.03265991224985e-12	18	0	0	239	6908
ko00770	Pantothenate and CoA biosynthesis	0.999999999997967	-2.03265991224985e-12	18	0	0	239	6908
hsa00511	Other glycan degradation	0.999999999997967	-2.03265991224985e-12	18	0	0	239	6908
ko00511	Other glycan degradation	0.999999999997967	-2.03265991224985e-12	18	0	0	239	6908
hsa03450	Non-homologous end-joining	0.999999999998466	-1.53420951785214e-12	13	0	0	239	6908
hsa00061	Fatty acid biosynthesis	0.999999999998466	-1.53420951785214e-12	13	0	0	239	6908
ko03450	Non-homologous end-joining	0.999999999998466	-1.53420951785214e-12	13	0	0	239	6908
ko00061	Fatty acid biosynthesis	0.999999999998466	-1.53420951785214e-12	13	0	0	239	6908
ko00900	Terpenoid backbone biosynthesis	1.00000000000177	1.77469883331405e-12	22	0	0	239	6908
hsa00900	Terpenoid backbone biosynthesis	1.00000000000177	1.77469883331405e-12	22	0	0	239	6908
hsa05320	Autoimmune thyroid disease	1.00000000000565	5.65292890300907e-12	52	0	0	239	6908
ko05320	Autoimmune thyroid disease	1.00000000000565	5.65292890300907e-12	52	0	0	239	6908
hsa00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1.00000000000584	5.84491649606873e-12	25	0	0	239	6908
ko00592	alpha-Linolenic acid metabolism	1.00000000000584	5.84491649606873e-12	25	0	0	239	6908
hsa00592	alpha-Linolenic acid metabolism	1.00000000000584	5.84491649606873e-12	25	0	0	239	6908
hsa00062	Fatty acid elongation	1.00000000000584	5.84491649606873e-12	25	0	0	239	6908
ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1.00000000000584	5.84491649606873e-12	25	0	0	239	6908
ko00062	Fatty acid elongation	1.00000000000584	5.84491649606873e-12	25	0	0	239	6908
ko00232	Caffeine metabolism	1.00000000000673	6.7270572753392e-12	5	0	0	239	6908
hsa00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1.00000000000673	6.7270572753392e-12	5	0	0	239	6908
ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1.00000000000673	6.7270572753392e-12	5	0	0	239	6908
hsa00232	Caffeine metabolism	1.00000000000673	6.7270572753392e-12	5	0	0	239	6908
ko00790	Folate biosynthesis	1.00000000000676	6.76471348442918e-12	14	0	0	239	6908
hsa00790	Folate biosynthesis	1.00000000000676	6.76471348442918e-12	14	0	0	239	6908
ko03410	Base excision repair	1.0000000000073	7.30486895744727e-12	33	0	0	239	6908
hsa03410	Base excision repair	1.0000000000073	7.30486895744727e-12	33	0	0	239	6908
hsa00531	Glycosaminoglycan degradation	1.00000000000935	9.35295266309845e-12	19	0	0	239	6908
ko00531	Glycosaminoglycan degradation	1.00000000000935	9.35295266309845e-12	19	0	0	239	6908
ko00785	Lipoic acid metabolism	1.00000000000935	9.35309012043469e-12	3	0	0	239	6908
hsa00780	Biotin metabolism	1.00000000000935	9.35309012043469e-12	3	0	0	239	6908
ko01220	Degradation of aromatic compounds	1.00000000000935	9.35309012043469e-12	3	0	0	239	6908
hsa01220	Degradation of aromatic compounds	1.00000000000935	9.35309012043469e-12	3	0	0	239	6908
hsa00785	Lipoic acid metabolism	1.00000000000935	9.35309012043469e-12	3	0	0	239	6908
ko00780	Biotin metabolism	1.00000000000935	9.35309012043469e-12	3	0	0	239	6908
ko00740	Riboflavin metabolism	1.00000000000968	9.68102608826304e-12	4	0	0	239	6908
hsa00290	Valine, leucine and isoleucine biosynthesis	1.00000000000968	9.68102608826304e-12	4	0	0	239	6908
ko00471	D-Glutamine and D-glutamate metabolism	1.00000000000968	9.68102608826304e-12	4	0	0	239	6908
hsa00471	D-Glutamine and D-glutamate metabolism	1.00000000000968	9.68102608826304e-12	4	0	0	239	6908
hsa00740	Riboflavin metabolism	1.00000000000968	9.68102608826304e-12	4	0	0	239	6908
ko00290	Valine, leucine and isoleucine biosynthesis	1.00000000000968	9.68102608826304e-12	4	0	0	239	6908
hsa00730	Thiamine metabolism	1.00000000000968	9.68102608826304e-12	4	0	0	239	6908
ko00730	Thiamine metabolism	1.00000000000968	9.68102608826304e-12	4	0	0	239	6908
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1.00000000000968	9.68409650229116e-12	11	0	0	239	6908
hsa00130	Ubiquinone and other terpenoid-quinone biosynthesis	1.00000000000968	9.68409650229116e-12	11	0	0	239	6908
hsa00910	Nitrogen metabolism	1.00000000001009	1.00891009777376e-11	17	0	0	239	6908
hsa00450	Selenocompound metabolism	1.00000000001009	1.00891009777376e-11	17	0	0	239	6908
ko00910	Nitrogen metabolism	1.00000000001009	1.00891009777376e-11	17	0	0	239	6908
ko00450	Selenocompound metabolism	1.00000000001009	1.00891009777376e-11	17	0	0	239	6908
hsa00472	D-Arginine and D-ornithine metabolism	1.0000000000108	1.07951980687915e-11	1	0	0	239	6908
ko00472	D-Arginine and D-ornithine metabolism	1.0000000000108	1.07951980687915e-11	1	0	0	239	6908
hsa05150	Staphylococcus aureus infection	1.00000000001135	1.13450465012847e-11	55	0	0	239	6908
ko05150	Staphylococcus aureus infection	1.00000000001135	1.13450465012847e-11	55	0	0	239	6908
ko04672	Intestinal immune network for IgA production	1.00000000001166	1.16589126862983e-11	47	0	0	239	6908
hsa04672	Intestinal immune network for IgA production	1.00000000001166	1.16589126862983e-11	47	0	0	239	6908
hsa05340	Primary immunodeficiency	1.00000000001178	1.17780485774191e-11	36	0	0	239	6908
ko05340	Primary immunodeficiency	1.00000000001178	1.17780485774191e-11	36	0	0	239	6908
hsa03050	Proteasome	1.00000000001202	1.20221058585225e-11	44	0	0	239	6908
ko03050	Proteasome	1.00000000001202	1.20221058585225e-11	44	0	0	239	6908
hsa00591	Linoleic acid metabolism	1.00000000001232	1.23168077076666e-11	29	0	0	239	6908
ko00030	Pentose phosphate pathway	1.00000000001232	1.23168077076666e-11	29	0	0	239	6908
hsa03440	Homologous recombination	1.00000000001232	1.23168077076666e-11	29	0	0	239	6908
ko03440	Homologous recombination	1.00000000001232	1.23168077076666e-11	29	0	0	239	6908
ko00591	Linoleic acid metabolism	1.00000000001232	1.23168077076666e-11	29	0	0	239	6908
hsa00030	Pentose phosphate pathway	1.00000000001232	1.23168077076666e-11	29	0	0	239	6908
hsa05310	Asthma	1.00000000001271	1.27100693736758e-11	30	0	0	239	6908
ko05310	Asthma	1.00000000001271	1.27100693736758e-11	30	0	0	239	6908
ko04330	Notch signaling pathway	1.00000000001338	1.33811881992527e-11	48	0	0	239	6908
hsa04330	Notch signaling pathway	1.00000000001338	1.33811881992527e-11	48	0	0	239	6908
hsa05140	Leishmaniasis	1.00000000001406	1.40608328644742e-11	72	0	0	239	6908
ko05140	Leishmaniasis	1.00000000001406	1.40608328644742e-11	72	0	0	239	6908
ko01040	Biosynthesis of unsaturated fatty acids	1.00000000001425	1.42451599327351e-11	23	0	0	239	6908
hsa04614	Renin-angiotensin system	1.00000000001425	1.42451599327351e-11	23	0	0	239	6908
ko04614	Renin-angiotensin system	1.00000000001425	1.42451599327351e-11	23	0	0	239	6908
hsa01040	Biosynthesis of unsaturated fatty acids	1.00000000001425	1.42451599327351e-11	23	0	0	239	6908
hsa05330	Allograft rejection	1.00000000001443	1.44288463616216e-11	37	0	0	239	6908
ko05330	Allograft rejection	1.00000000001443	1.44288463616216e-11	37	0	0	239	6908
hsa04122	Sulfur relay system	1.00000000001496	1.49634240905856e-11	10	0	0	239	6908
ko00920	Sulfur metabolism	1.00000000001496	1.49634240905856e-11	10	0	0	239	6908
ko04122	Sulfur relay system	1.00000000001496	1.49634240905856e-11	10	0	0	239	6908
hsa00920	Sulfur metabolism	1.00000000001496	1.49634240905856e-11	10	0	0	239	6908
ko00860	Porphyrin and chlorophyll metabolism	1.00000000001666	1.66617537845892e-11	42	0	0	239	6908
hsa00860	Porphyrin and chlorophyll metabolism	1.00000000001666	1.66617537845892e-11	42	0	0	239	6908
hsa04977	Vitamin digestion and absorption	1.00000000001712	1.71176514854617e-11	24	0	0	239	6908
ko04977	Vitamin digestion and absorption	1.00000000001712	1.71176514854617e-11	24	0	0	239	6908
hsa00670	One carbon pool by folate	1.00000000001781	1.7809839925502e-11	20	0	0	239	6908
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1.00000000001781	1.7809839925502e-11	20	0	0	239	6908
hsa00100	Steroid biosynthesis	1.00000000001781	1.7809839925502e-11	20	0	0	239	6908
hsa00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1.00000000001781	1.7809839925502e-11	20	0	0	239	6908
ko00670	One carbon pool by folate	1.00000000001781	1.7809839925502e-11	20	0	0	239	6908
ko00100	Steroid biosynthesis	1.00000000001781	1.7809839925502e-11	20	0	0	239	6908
ko05332	Graft-versus-host disease	1.00000000001808	1.80781382448795e-11	41	0	0	239	6908
hsa04975	Fat digestion and absorption	1.00000000001808	1.80781382448795e-11	41	0	0	239	6908
hsa05332	Graft-versus-host disease	1.00000000001808	1.80781382448795e-11	41	0	0	239	6908
ko04975	Fat digestion and absorption	1.00000000001808	1.80781382448795e-11	41	0	0	239	6908
ko03020	RNA polymerase	1.00000000001822	1.82151399221688e-11	31	0	0	239	6908
hsa03020	RNA polymerase	1.00000000001822	1.82151399221688e-11	31	0	0	239	6908
hsa00480	Glutathione metabolism	1.0000000000183	1.83046986535824e-11	51	0	0	239	6908
ko00480	Glutathione metabolism	1.0000000000183	1.83046986535824e-11	51	0	0	239	6908
ko04130	SNARE interactions in vesicular transport	1.00000000001891	1.89104679093645e-11	34	0	0	239	6908
hsa04130	SNARE interactions in vesicular transport	1.00000000001891	1.89104679093645e-11	34	0	0	239	6908
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	1.00000000001983	1.98262408950435e-11	15	0	0	239	6908
hsa00533	Glycosaminoglycan biosynthesis - keratan sulfate	1.00000000001983	1.98262408950435e-11	15	0	0	239	6908
hsa04612	Antigen processing and presentation	1.00000000001991	1.99062335256252e-11	77	0	0	239	6908
ko04612	Antigen processing and presentation	1.00000000001991	1.99062335256252e-11	77	0	0	239	6908
hsa00830	Retinol metabolism	1.00000000002004	2.00402371066772e-11	65	0	0	239	6908
ko00830	Retinol metabolism	1.00000000002004	2.00402371066772e-11	65	0	0	239	6908
ko05033	Nicotine addiction	1.00000000002256	2.25588670678827e-11	40	0	0	239	6908
hsa05033	Nicotine addiction	1.00000000002256	2.25588670678827e-11	40	0	0	239	6908
hsa04740	Olfactory transduction	1.00000000002349	2.34867803078243e-11	404	0	0	239	6908
ko04740	Olfactory transduction	1.00000000002349	2.34867803078243e-11	404	0	0	239	6908
ko04966	Collecting duct acid secretion	1.00000000002431	2.43083457265933e-11	27	0	0	239	6908
hsa04966	Collecting duct acid secretion	1.00000000002431	2.43083457265933e-11	27	0	0	239	6908
hsa04950	Maturity onset diabetes of the young	1.00000000002459	2.45914055123532e-11	26	0	0	239	6908
ko04950	Maturity onset diabetes of the young	1.00000000002459	2.45914055123532e-11	26	0	0	239	6908
hsa05204	Chemical carcinogenesis	1.0000000000284	2.84010372537224e-11	81	0	0	239	6908
ko05204	Chemical carcinogenesis	1.0000000000284	2.84010372537224e-11	81	0	0	239	6908
hsa04142	Lysosome	1.00000000003209	3.20856491537985e-11	123	0	0	239	6908
ko04142	Lysosome	1.00000000003209	3.20856491537985e-11	123	0	0	239	6908
hsa05322	Systemic lupus erythematosus	1.00000000003892	3.89219476358681e-11	134	0	0	239	6908
ko05322	Systemic lupus erythematosus	1.00000000003892	3.89219476358681e-11	134	0	0	239	6908
